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ABSTRACT

GQ NONCANONICAL ROLES IN TRANSLATIONAL REGULATION

By
Brett A. DeMarco
August 2018

Dissertation supervised by Dr. Mihaela-Rita Mihailescu

This study investigates protein nucleic acid interactions, focusing on G-quadruplex (GQ)
forming DNA/RNA in human disease. GQ structures are formed in DNA/RNA, when four
guanine residues form planar tetrads stabilized by Hoogsteen base pairing, that stack forming a
GQ structure stabilized by potassium ions. These GQ structures are targeted by the arginineglycine-glycine (RGG) RNA-binding domain.
Fragile X mental retardation protein (FMRP), a translation regulator protein implicated in
the fragile X syndrome, has an RGG domain and has been previously shown to interact with
neuronal GQ forming messenger RNA (mRNA). We have investigated three neuronal FMRP
mRNA targets that we predicted form GQ structures and analyzed their interactions with FMRP.
One mRNA target was NR2B, an important protein in the synaptic density. Our work shows that
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a GQ forms in the 3’-UTR of NR2B and that this structure is sufficient for the NR2B mRNA
recognition by FMRP.
The second neuronal FMRP target we investigated was PSD-95, which is post synaptic
density protein 95, a protein important to healthy synapse functioning. We showed that two GQ
structures are forming in the PSD-95 3’-UTR, encompassing the binding site of the miRNA125a, a non-coding microRNA that regulates the translation of PSD-95 mRNA. Moreover,
depending on its phosphorylation status, FMRP acts as a switch, mediating the binding of
miRNA-125a and modulating the activation or deactivation of the PSD-95 translation.
Further investigation of noncanonical roles for GQ in translation regulation led us to
investigate a GQ structure in close proximity to an alternative polyadenylation site in the 3’-UTR
of the brain derived neurotrophic factor (BDNF) gene. Our results suggest that the GQ structure
works to preferentially choose one poly(A) over another, ultimately affecting the translation of
BDNF.
Lastly, we investigated GQ formation in pre-miRNA-149 and how the GQ leads to a
disruption of the canonical long extended hairpin and eventually maturation of the microRNA
miR-149, which will lead to a disruption of mRNA’s translational regulation.
These four projects demonstrate unique roles for the GQ structure, contributing to our
understanding of GQ role in translational regulation.
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Chapter 1: GQ Structure and Function
Chapter 1.1 Introduction. When DNA is brought up in conversation the first thing that comes
to mind is the iconic Watson-Crick double helix structure, discovered in 1953 [1]. Although this
is the canonical structure adopted by DNA, there are many important noncanonical structures
that are responsible for the regulation of various biological processes [2]. One such structure is
the G-quadruplex (GQ). G-quartets are formed when four guanine nucleotides connected through
Hoogsteen hydrogen bonding assemble into a square planar arrangement that is stabilized by K+
ions, these G-quartets stack on one another and form the GQ (Figure 1) [3,4].

Figure 1. GQ Structure. (A) the G-quartet structure stabilized by a central potassium ion. (B)
sample intramolecular three plane antiparallel GQ. (C) sample intramolecular three plane
parallel GQ. (D) sample intermolecular three plane antiparallel GQ. (E) sample intermolecular
parallel GQ.
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Intramolecular GQs can form when the DNA/RNA sequence has four G-stretches
containing at least two guanines separated by other nucleotides that will be contained in the
loops connecting the G-quartets. The standard formula for GQ formation is: GxN1-7GxN1-7GxN17Gx,

where X is the number of guanines in the G-stretch (2-5) and N is the number of nucleotides

in the loops of the GQ [5]. The loop length of the GQ can have a significant effect on the
thermodynamic stability of the structure; GQs with a single nucleotide in the loop have been
shown to be more stable than those with more nucleotides in the loop [6, 7]. Monovalent cations
can stabilize the GQ by intercalating between planes and coordinating with the O6 atoms within
the guanines forming the G-quartet. K+ ions have the most favorable interactions with the GQ
structure due to their size mimicking the hydration shell of the inner oxygens of the G-quartet
[8]. Although other monovalent cations (such as Na+ and Li+) can coordinate with GQ, the net
free energy realized by coordinating with potassium is the greatest (-1.7 kcal/mol) leading to the
most stable GQ structure [9]. Overall, the final stability of a GQ will depend on the salt
concentration, loop length, and number of planes (G-quartets stacking) [10].
Chapter 1.2 GQ regulatory biological functions. The GQ was first observed in DNA
telomeres [11], which contain a high abundance of TTAGGG repeats [12]. Normal telomere
processing requires a free single-stranded 3’-end to react and can be deactivated by the formation
of GQ at the 3’-end [13]. Human telomeric GQ structures regulate the processing of telomeres
and are linked to tumor growth in cancer [14]. Huppert and Balasubramanian performed a
bioinformatics study in 2005 and concluded that as many as 367,000 predicted GQs could be
forming [15]. In addition to being observed in telomeres, GQ structures have been predicted to
exist in >40% of promoters throughout the human genome [16]. These data suggest that the GQ
structure plays an important role in transcription regulation. Subsequent studies on KRAS [17],
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c-MYC [18], and RET [19] (to name a few) reveal that GQ does have a regulatory effect on
transcription. Studies have investigated the prevalence of the GQ structure outside of mammals
and discovered the structure is highly conserved within plants as well, having a similar global
genetic regulatory function [20].
Most of these studies have investigated the formation of GQ structure in DNA, however
GQ can readily form in RNA as well [21]. In fact, RNA GQ are even more likely to form since
RNA is single stranded so there will be less structural competition, unlike in DNA where the
Watson-Crick double stranded helix will be a competitor for the GQ structure. RNA GQs are as
important as DNA GQs and are involved in a diverse set of biological functions [22]. DNA GQs
require the presence of potassium ions for folding, while RNA GQs of identical sequence can
fold even in the absence of these ions, but have low stability [23]. GQ formation in RNA has also
been observed in the 5’-UTR and reports show the structure acts as a translational repressor [24,
25]. Another well-studied case is the NRAS gene, which has a GQ in the 5’-UTR that, similarly,
represses translation [26]. This clearly shows that the GQ structure is acting as a regulator of
translation, but the biological role of the GQ structure is not limited to the 5’-UTR. RNA GQ
structures have also been observed in the 3’-UTR of a significant number of human genes
(roughly 15%) [27]. The 3’-UTR of mRNAs is known to harbor binding sites for regulatory
RNA-binding proteins (RBPs) and microRNAs (miRNAs), and GQ formation near these binding
sites can interfere with their mechanisms of regulation. One recent study shows GQ formation in
the 3’-UTR of p53 pre-mRNA to be important for the 3’-end processing [28]. Shank1 RNA is an
important neuronal mRNA for dendritic and synaptic function, and a highly conserved GQ is
found in it’s 3’-UTR that mediates interactions with fragile X mental retardation protein
(FMRP), a known RBP that regulates neuronal mRNA expression [29]. The NR2B gene has also

3

been shown to have GQ-mediated interactions with FMRP in it’s 3’-UTR similar to Shank1 [30].
PSD-95 is another important neuronal mRNA that has been shown to harbor a GQ in its 3’-UTR
[31]. Insulin-like growth factor II (IGF-II) has a specific cleavage site directly in front of a GQ
forming in its 3’-UTR that leads to a differently processed transcript [32].
Additionally, the GQ structure has been implicated to be involved in the miRNA pathway
by potentially modulating the production of mature miRNA [33]. miRNAs are short noncoding
RNAs that have been shown to have a significant effect on many biological functions by way of
regulating transcription and translation [34]. Thus, miRNAs are one of the most important
regulatory factors in gene expression for maintaining homeostasis. Dysregulation of miRNA has
been linked to many different cancers [35 and references therein] and several studies have found
that by manipulating the expression of the disease-related miRNA the levels of cancerous cells
can be regulated [36].
Considering all the biological functions that GQs regulate, it makes sense to consider
them as therapeutic targets to treat human disease [37]. The study of small molecules that
stabilize or destabilize GQ structures can lead to the development of drugs that can specifically
target GQ. For instance, tetratosylate, TMPyP4, has been shown to destabilize RNA GQ, while it
can stabilize DNA GQ in human telomeres [38, 39]. Porphyrin molecules, such as TMPyP4,
interact with GQ by stacking with the G-quartets [40]. This method of targeting is not selective
however, and leaves room for nonspecific interactions that could be off-target from the desired
GQ structure. This lack of specificity is one challenge in the therapeutic development process for
GQ binding drugs. By understanding how GQ structures assemble naturally, we can gain insight
into how they function within their specific disease associated system and potentially better
target them in a therapeutic aspect.
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Chapter 1.3 GQ and FMRP. Fragile X Syndrome (FXS), an inherited developmental disorder,
is caused by the trinucleotide CGG expansion and silencing of the FMR1 gene that codes for the
fragile X mental retardation protein (FMRP) [41]. Loss of FMRP results in disruption of the
molecular composition of the post synaptic density (PSD), affecting normal dendritic spine
development and synaptic function [42, 43]. FMRP is an RNA-binding protein whose function
is strongly implicated in mRNA translation regulation mechanisms, and whose absence severely
affects the spatiotemporal dynamics of mRNA in neurons [44, 45]. It is suggested that FMRP
locally controls the synthesis of various protein components of PSD, by acting as a switch that
suppresses/allows their mRNA translation depending on the current cellular requirements [46,
47]. This translational switch is believed to be impaired in FXS patients where FMRP is absent,
leading to an abnormal dendritic spine phenotype.
Dendritic spines are important excitatory synaptic networks crucial for proper
communication among neurons [48]. There are several confirmed mRNA targets of FMRP that
are encoding for important scaffold proteins in PSD and whose translational disruption has been
linked to FXS phenotype. Using HITS-CLIP to identify FMRP target mRNAs in brain in vivo,
several PSD components were identified that include PSD-95 and Shank1-3, as well as mRNAs
encoding NMDA receptor subunits, NR1, NR2A, NR2B and NR3A [49, 50]. These PSD
scaffold proteins play essential roles in the majority of synaptic functions, being responsible for
trafficking, anchoring and clustering of glutamate receptors and adhesion molecules, in addition
to their role of linking the postsynaptic receptors to their downstream signaling proteins [51]. For
instance, Mudashetty et al. (2011) showed that there is a dysregulated translation of PSD-95
mRNA when FMRP is absent, while Schutt et al. (2009) [52] identified disrupted levels of
Shank1, SAPAP1-3, PSD-95 and glutamate receptor subunits NR1 and NR2B in FMRP knock-
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out mice mimicking the disease. This led us to believe that these mRNAs are likely being
regulated by FMRP.
FMRP shares about 60% of amino acid identity with its autosomal paralogs, FXR1P and
FXR2P [53, 54]. Even though it was proposed that these paralogs could partially compensate for
the loss of FMRP, it was later shown that the expression of FXR1P and FXR2P is not altered in
patients with fragile X syndrome or in Fmr1 knockout mice [55].
FMRP is mainly located in the cytoplasm, however, due to a nuclear localization signal
(NLS) and a nuclear export signal (NES) within its sequence, it can traffic between the
cytoplasm and nucleus (see figure 2 for schematic of FMRP) [56]. In the nucleus, FMRP
associates with specific mRNAs and other proteins as part of larger ribonucleoprotein complexes
that can later be transported to dendrites where they control the expression of certain proteins in
response to synaptic stimulation [42].

Figure 2. Schematic of FMRP. Representation of FMRP, highlighting the nuclear
localization signal (NLS), K-homology domains (KH1 & KH2), the nuclear export signal
(NES), the site of phosphorylation S500D (the position where we substitute serine 500 for
aspartic acid to create the FMRP phosphomimic), and the RGG box.
Two types of RNA-binding motifs are of special interest for FMRP–RNA binding, two of
its ribonucleoprotein K homology domains (KH1 and KH2) and a specific group of arginineglycine-glycine repeats, referred to as its RGG box (figure 2) [57, 58]. It was shown that the
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FMRP RGG box has high affinity for specific GQ structures of neuronal mRNA targets [29, 30,
59, 60], whereas the KH domains recognize another specific RNA structure called a kissing
complex [61]. The data present in the literature outlines a narrative where FMRP is an important
neuronal RBP that targets RNA through the GQ motif. In this study we add to this narrative by
elucidating a deeper mechanistic understanding of how and why FMRP is targeting GQ.
Overall, RNA binding proteins that specifically target GQ secondary structure have been
shown to have various different ways of regulating translation. FMRP was observed binding to a
GQ in its own coding region and blocking its own translation [59]. FMR2 was found to target
GQ and be involved in alternative splicing [62]. We know that GQ-RBP interactions are
important to the regulation of biological functions, but the mechanism behind each interaction is
unique. Thus, the study here investigates the details of how GQ interacts with proteins and other
factors to exert regulation control in these complex systems.
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Chapter 2: Fragile X mental retardation protein interactions with a GQ structure in the 3′untranslated region of NR2B mRNA
Chapter 2.1 Introduction. PSD scaffold proteins play essential roles in synaptic functions,
including trafficking, anchoring and clustering of glutamate receptors. Schutt et al. (2009)
identified disrupted levels glutamate receptor subunits NR1 and NR2B in FMRP knock-out mice
mimicking the FXS disease. Given that these scaffold proteins are essential members of the PSD
network, any disruption in their expression levels would lead to an abnormal synapse
development and function. Schutt et al. (2009) examined whether the changes in scaffold protein
levels affect the abundance of glutamate receptors in the PSD, given the role of these scaffold
proteins in anchoring neurotransmitter receptors in the post synaptic membrane [49]. They found
elevated levels of NR1 in both the neocortex and hippocampus, of NR2B in the hippocampus
and of GluR1 in the neocortex of FMRP-deficient mice as compared with wild type mice. In
contrast, only a slight increase of glutamate receptor subunits NR2A, GluR2/3, and GluR4 was
found in the PSD fractions of the FMRP-deficient mice. Moreover, this study has also shown
that FMRP associates in vivo with mRNAs encoding for scaffold proteins and glutamate receptor
units (such as PSD-95, SAPAP1, SAPAP2, SAPAP3, Shank1, NR1 and NR2B) and concluded
that the observed elevated protein levels in the FMRP-deficient mouse brain result from their
dysregulated translation.
The exact details of the mechanisms by which FMRP controls the translation of its
mRNA targets are not known. It has been shown that the arginine-glycine-glycine (RGG)
domain of FMRP has high affinity for specific GQ structures of neuronal mRNA targets.
Previously, we have directly shown that the interactions between FMRP and mRNAs of the
scaffold PSD-95 and Shank1 proteins are mediated via stable GQ structures formed within the
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3’-UTRs of these mRNAs [29, 30]. In this work, we used biophysical methods to show that a
comparable GQ structure forms in the glutamate receptor subunit NR2B mRNA that is coding
for a subunit of N-methyl-D-aspartate (NMDA) receptors, a class of ligand-gated ions channels
acting as excitatory amino acid receptors [63]. Our results indicate that this GQ structure is
recognized with high affinity and specificity by FMRP both in vitro and in vivo, suggesting a
common theme for FMRP recognition of its dendritic mRNA targets.

Table 1. Sequences used in the NR2B project.

Chapter 2.2 NR2B mRNA forms an intramolecular GQ structure with parallel topology. It
has been shown that for a subset of mRNAs, FMRP-facilitated translational control is carried on
in regions located within their 3’-UTR [55]. We have previously demonstrated the presence of
GQ structures in the 3’-UTR regions of several FMRP mRNA targets such as Semaphorin 3F,
PSD-95, Shank1, that are bound specifically and with high affinity by both FMRP and its
phosphorylated mimic FMRP S500D [29, 30, 57]. Given that NR2B mRNA has been found to be
associated with FMRP in whole mouse brain homogenates [49] and directly crosslinked in vivo
[46] we analyzed its sequence for the potential to adopt GQ structures. We used an online GQ
prediction software QGRS Mapper [64], which predicted the existence of a high score GQ in the
NR2B mRNA 3’-UTR (NM_000834.3, position 4659) (Figure 3, the Gs predicted to engage in
GQ formation are underlined).
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Figure 3. NR2B GQ structure. (A) 32 nt guanine rich sequence located in the 3’-UTR of
NR2B mRNA (NM_000834.3, position 4659) predicted to form GQ (guanine triplets proposed
to be involved in the structure are underlined). (B) Arrangement of the predicted GQ structure
in the NR2B mRNA. QGRS Mapper software was used for the prediction
(http://bioinformatics.ramapo.edu/QGRS/analyze.php). Adenine replaced by the 2-amino
purine fluorescent analog is circled in red.
To determine if such a structure forms in the NR2B mRNA 3’-UTR we have produced by
in vitro transcription reaction a 32 nucleotide (nt) sequence containing this G-rich segment. The
formation of GQ structures in this RNA was tested first by one-dimensional (1D) 1H NMR
spectroscopy in the presence of increasing concentrations of K+ ions. This technique is
commonly used to detect GQ structures in DNA/RNA since the guanine imino protons engaged
in GQ formation have a signature chemical shift between 10 and 12 ppm [65, 66].
We observed a strong signal in the region 10-12 ppm for the NR2B mRNA even in the
absence of K+, indicating GQ formation (Figure 4, bottom spectrum). Additionally, low intensity
and broad resonances were observed in the region 12-14.5 ppm, indicative of the presence of a
minor alternate structure involving Watson-Crick base pairs.
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No significant changes in imino proton resonances were observed after titration of 5 and 10 mM
K+. However, broadening of the spectra was observed after the addition of 50 and 100 mM KCl,
suggesting that additional GQ conformations might be supported by increased amount of salt.
Additionally, the GQ structures might form higher order complexes stabilized by the K+ ions.
The analysis of the 32-nt NR2B mRNA sequence revealed the possibility of formation of
alternate GQ structures containing two plane G-quartets, that were also predicted by the QGRS
Mapper, but with lower probability scores than the highest score three-plane GQ (Figure 3). For
our studies we also created an NR2B mutant sequence, table 1, in which we interrupted the Gstretches with C nucleotides to disrupt the GQ formation. QGRS mapper did not predict this
sequence to fold into a GQ and we characterized it in concert with the WT NR2B to prove this
(sequence found in Table 1). As seen in figure 4B, there are no observed resonances in the GQ
imino proton region of the NR2B mutant sequence, instead resonances indicative of WatsonCrick base pairs are present.

Figure 4. NR2B 1H NMR of GQ structure. 1H NMR spectra of 350 µM NR2B mRNA at
various concentrations of K+ ions in 10 mM cacodylic acid buffer, pH 6.5, at 25C.
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Next, we performed 20% non-denaturing polyacrylamide gel electrophoresis of the 32-nt
NR2B mRNA in 0.5 X TBE buffer to obtain additional information about its GQ structure
(figure 5).

Figure 5. Native PAGE of NR2B mRNA. 20% non-denaturing polyacrylamide gel of NR2B
mRNA in 0.5 X TBE buffer in increasing salt concentrations. Lane 1: 10 μM NR2B mRNA no
salt; Lanes 2–7: 5–150 mM KCl concentration. The RNA samples were annealed by boiling
for 5 minutes in the presence of salt and then incubated at room temperature for 10 minutes.
The gels were visualized by UV shadowing at 254 nm.
Two distinct bands are present even in the absence of K+ (lane 1), whereas upon
increasing the K+ at 150 mM, these bands become smeared. These results are consistent with the
NMR spectroscopy results in the presence of higher concentrations of salt (Figure 5, 50, and 100
mM KCl), indicating the presence of multiple GQ conformations and/or possible aggregation. It
is known that the stability of GQs highly depends on their architecture, with more G-quartet
planes stacked within the GQ increasing the overall thermodynamic stability of the structure
[67]. In our proposed 32-nt NR2B mRNA fragment, there is only one three-plane intramolecular
GQ that could be possibly formed due to existence of only four guanine triplets (underlined in
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figure 3), and other GQ structures would involve less stable two-plane arrangements. Another
possibility could be that guanine residues engage in an intermolecular arrangement that will
result in a GQ formed from different strands.
To examine if intramolecular or intermolecular GQ conformations are formed by the 32nt NR2B mRNA fragment, we performed UV thermal denaturation experiments at a fixed KCl

Figure 6. Circular dichroism of NR2B mRNA. CD spectra of NR2B mRNA in increasing
salt concentration at 25C. 10 µM RNA sample was suspended in 10 mM cacodylic acid
buffer and KCl was titrated in the range 1-100 mM. The spectra were corrected by subtracting
10 mM cacodylic acid buffer contributions.
concentration (75 mM KCl) and variable RNA concentration in the range 10-40 µM, varying the
temperature from 25-95C and monitoring the absorbance changes at 295 nm, wavelength
sensitive to GQ denaturation [68] (Data not shown. *completed by Ayana Underwood.) For
intramolecular species the melting temperature is independent of the RNA concentration
(chapter 7, materials and methods, equations 1 and 2). A clearly defined transition with a
melting temperature, Tm, of 68°C was observed at all RNA concentrations investigated,
suggesting that the GQ conformation is intramolecular.
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To examine the fold of the NR2B mRNA GQ structure we employed circular dichroism
(CD) spectroscopy, a technique widely used for GQ analysis due to unique signature responses
of different GQ folding arrangements [69, 70]. For parallel GQ structure formation, a positive
band at around 265 nm and a negative band at around 240 nm have been observed, whereas the
signatures of an antiparallel GQ structure are a negative band at around 260 nm and a positive
band at around 295 nm [71, 72]. We performed the analysis in K+ concentrations ranging from 0100 mM and observed that the presence of a positive band at 265 nm and a negative band at 240
nm, even in the absence of KCl, indicating that NR2B mRNA folds into a parallel GQ (Figure 6)
[73]. The intensities of the bands increased as K+ was titrated, implying that salt is necessary to
improve stability. However, the intensities did not change significantly from 5-100 mM, this
could be interpreted as the capability of RNA to form a fully stable GQ structure in the presence
of low ionic strength. However, physiological potassium concentration is approximately 150 mM
[74] which leans towards the formation of a more stable GQ.
In summary, our biophysical analysis determined that the G-rich stretch within the NR2B
mRNA 3’-UTR folds into parallel, GQ structures, the most stable of which is intramolecular,
parallel and contains three G-quartet planes (figure 3).
Chapter 2.3 Interaction of FMRP with the NR2B mRNA GQ. Previously it has been shown
that the FMRP interactions with NR2B mRNA are localized within the mRNA’s 3’-UTR [55].
Thus, we investigated whether the 32-nt GQ forming NR2B mRNA fragment is sufficient for
FMRP recognition, by analyzing its interactions with the full-length FMRP (isoform 1), as well
as with its phosphorylated mimic FMRP S500D [75] by fluorescence spectroscopy. The FMRP
S500D has been included since it has been shown that the phosphorylation status of FMRP plays
a role in mRNA translation control, wherein phosphorylated FMRP acts as a translation
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inhibitor, whereas upon its dephosphorylation triggered by synaptic input, it supports the mRNA
translation [44]. FMRP and FMRP S500D were in vitro expressed and purified according to the
protocol previously established in our laboratory [76]. It is important to note that FMRP S500D
is only a phosphomimic as a serine has been replaced with an aspartic acid to mimic the
phosphorylation of a serine. This is not a perfect replication of phosphorylation, but due to
aspartic acid being chemically similar to phosphor-serine it is an acceptable way to create a
protein that is constantly in its phosphorylated state. We have designed a fluorescently labelled
NR2B 2AP mRNA, in which the adenine at position 5 was replaced with 2-aminopurine (2AP)
(Figure 3, adenine 5 is circled). 2AP is a highly fluorescent analog of adenine whose steady-state
fluorescence is sensitive to changes in its microenvironment [77, 78]. A 200 nM RNA sample
was prepared in 10 mM cacodylic acid buffer pH 6.5 and 50 nM increments of either of FMRP
or FMRP S500D were titrated. The resulting binding curves were fit with equation 4 (Chapter 7,
Materials and Methods), to determine the dissociation constants, Kd, of 370 ± 29 nM for the
complex formed by NR2B mRNA with FMRP and of 201 ± 25 nM for the complex formed with
FMRP S500D (*Data not shown, completed by Snezana Stefanovic). These dissociation constant
values are within range with those reported for the binding of the full length FMRP or FMRP
S500D to GQ structures formed within other mRNA targets such as Shank1 [29], FMR1 [79],
Semaphorin 3F. The dissociation constant values for FMRP and FMRP S500D binding to NR2B
mRNA yield a free energy of binding of G0b = -8.7  0.1 kcal/mol and of G0b = -9.1  0.1
kcal/mol, respectively, hence a difference of only 0.4 kcal/mol in binding free energy for FMRP
S500D, versus unphosphorylated FMRP. This is not a significant amount of energy and accounts
for less than a single hydrogen bond.
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Finally, to confirm the interactions of the NR2B GQ with endogenous FMRP, Kathryn
Moss, a student in our collaborator’s, Dr. Gary Bassell, lab performed a biotin-RNA pull down
assay using a biotin labelled 32-nt NR2B mRNA probe that was incubated with lysates from E17
mouse brain and further precipitated with NeutrAvidin agarose. It is clear from the Western blot
analysis that FMRP interacts with NR2B mRNA probe (Figure 7, lane 4). The presence of two
bands suggests that the NR2B mRNA probes pulled down more than one FMRP isoform that
exists in the mouse brain lysates. As expected, a control unrelated HCV RNA probe did not pull
down FMRP (Figure 7, lane 3).
In this study we have shown for the first time that a GQ structure forms within 3’-UTR of
the NR2B mRNA. We have also proven that both FMRP and its phosphorylated mimic FMRP
S500D bind with nM affinity to this GQ, which also interacts with endogenous FMRP from E17
mouse brain lysates.

Figure 7. Western blot analysis of NR2B in vivo. Western blot analysis of FMRP interaction
with GQ within NR2B mRNA. 5’-biotin labelled NR2B mRNA probe was incubated with E17
mouse brain lysate. Probes were precipitated with NeutrAvidin agarose beads and co-purified
FMRP and SMN protein was assessed by immunoblotting. Lane 1: 15% of brain lysate input
showing existence of FMRP; Lane 2: No detection of FMRP or SMN when the probe is not
present; Lane 3: No detection of FMRP and SMN using HCV probe; Lane 4: FMRP detected
with NR2B mRNA probe.
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Thus, our results indicate that from the entire NR2B mRNA that has been shown to co-IP
with FMRP [49], only a 32-nt GQ located in its 3’-UTR is sufficient to act as a recruiter of
FMRP. NR2B mRNA joins other dendritic mRNAs, such as PSD-95 and Shank1 [29, 31], that
have been shown to adopt one or more GQ structures in their 3’-UTR which are recognized by
FMRP with high affinity and specificity, suggesting a common mechanism of recognition. In the
case of PSD95 mRNA these GQ structures seem to be implicated together with FMRP and the
microRNA mir-125a in mediating the translation of their mRNA. Further investigations are
underway in our laboratories to determine if there are microRNAs that, similar to the case of
PSD-95 mRNA, work in conjunction with FMRP to control the translation of NR2B mRNA.
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Chapter 3: FMRP - GQ mRNA - miR-125a interactions: implications for miR-125a
mediated translation regulation of PSD-95 mRNA
Chapter 3.1 Introduction. There is evidence that FMRP phosphorylation plays a significant
role in mediating translation regulation of synaptic plasticity proteins [44]. The primary site of
phosphorylation on FMRP is the S500 residue in humans. Previous reports show that
endogenous FMRP exists in both unphosphorylated and phosphorylated forms; phosphorylated
FMRP is the predominant species present in dendritic granules [80].
Additionally, FMRP is believed to control the production of synaptic plasticity proteins
in response to external stimuli, such as synaptic signals [81]. Metabotropic glutamate receptor
(mGluR) activation triggers protein phosphatase 2A (PP2A) to rapidly dephosphorylate FMRP,
in less than 30 seconds, with re-phosphorylation via ribosomal S6 kinase starting after 2 minutes
[82, 83]. The phosphorylation state of FMRP is relevant to translation because reports in the
literature show that phosphorylated FMRP inhibits the translation of its target mRNAs, while
unphosphorylated FMRP allows translation to proceed [79].
PSD-95, postsynaptic scaffold protein 95, is one neuronal mRNA target regulated by
FMRP and microRNA-125a [31, 84, 85]. PSD-95 belongs to the membrane-associated guanylate
kinase family (MAGUK) and is essential for proper synapse functioning and glutamate receptor
localization [81, 86]. A G-rich region in the PSD-95 mRNA has been shown to be pivotal to the
binding of FMRP and when miRNA-125a is bound to PSD-95 mRNA in conjunction with
FMRP the translation of PSD-95 is reversibly inhibited [44]. When FMRP is phosphorylated and
the miR-125a-guided RISC (RNA-inducing silencing complex) bind PSD-95 mRNA translation
is inhibited, but when FMRP is dephosphorylated in response to synaptic input, the RISC
complex dissociates from PSD-95 mRNA, reversing the translation inhibition [44].
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In a previous study from our lab, we showed that the G-rich area within the 3’-UTR of
PSD-95 mRNA encompassing the binding site for miR-125a adopts multiple GQ conformations
some of which make accessing the miR-125a binding site impossible (Fig 8A) [31]. Here, we
inquired if the role of FMRP in regulating PSD-95 mRNA translation is to remodel the mRNA
structure, by binding to one or more GQs in which the miR-125a binding site could be
exposed/hidden, favoring the conformation in which the miR-125a site would be exposed. Our
findings point towards a mechanism by which FMRP binds to the stable GQ structures within
mRNA and depending on its phosphorylation status recruits the miR-125a-loaded RISC through
its direct interactions miR-125a and potentially with Ago2, contributing to the increased stability
of the RISC-PSD-95 mRNA complex.

Table 2. Sequences used in the PSD-95 project.
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Figure 8. Proposed structures of the PSD-95 Q1 and Q2 GQs. PSD-95 Q1-Q2 encompasses
both the Q1 and Q2 GQs. Q1 is shown in either the Q11245 conformation (A) that masks the
miR-125a binding site or Q11234 (B) that exposes it, respectively. The miR-125a proposed
binding site is shown in red, with the recognition site for its seed sequence being located in the
linker between Q11234 and Q2. Adenines 4162 and 4193 (circled in grey) were replaced with
the fluorescent analog 2-amino purine (2-AP) for the fluorescence spectroscopy experiments in
the isolated Q11234 and Q2 GQs, respectively.
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Chapter 3.2 Interactions of the FMRP RGG box with the GQs formed within PSD-95
mRNA. It has been proposed that the FMRP phosphorylation plays a significant role in
mediating its translation regulator function by binding to mRNA targets and allowing the
balanced production of synaptic plasticity proteins [43, 44]. FMRP has been shown to
specifically bind to GQ structures formed within its mRNA targets through the involvement of
its RGG box domain [29, 30, 55, 57]. Muddashetty et al. demonstrated that the 3’UTR of PSD95 mRNA contains specific binding sites for both FMRP and the microRNA miR-125a, that
cooperate to regulate PSD-95 mRNA translation, which is dysregulated in neurons from Fmr1
knockout mice [44]. Previously Bassell et al. showed that FMRP binds a G-rich region on the
3’UTR of PSD-95 mRNA [31] that overlaps with miR-125a binding site [44]. The proposed
model of the PSD-95 mRNA translation control suggests that FMRP remains bound to the
mRNA

in

both its

phosphorylated

and

unphosphorylated

states,

but

the

protein

dephosphorylation in response to mGluR signaling triggers the miR-125a-guided RISC
dissociation, allowing translation to occur [44].
In a previous study [31] we have shown that the PSD-95 3’-UTR G-rich region that
contains the miR-125a binding site forms two GQ structures, named Q1 and Q2 (Figure 8).
PSD-95 Q1 [nucleotides (nt) 4152–4177] is highly dynamic being able to adopt multiple GQ
conformations, only one of which exposes the miR-125a binding site (Figure 8), whereas PSD95 Q2 [nt 4190–4204] adopts a stable GQ structure (Figure 8B). Q11234 [nt 4152–4170] is a
truncated version of Q1 that lacks the last 7 nt, being locked in a single conformation. We
hypothesized that FMRP binds the Q1, Q11234 and Q2 GQs, potentially playing a role in
modulating the accessibility of the miR-125a to its binding site on PSD-95 mRNA.

21

Given that the FMRP domain that binds GQ structures is its RGG box we initially
analyzed the FMRP RGG box domain interactions with these GQs by electromobility shift
assays in 20% non-denaturing polyacrylamide gels in 0.5 X TBE buffer, using a chemically
synthesized RGG peptide (FMRP RGG). The formation of the RNA-FMRP RGG complex was
observed as a disappearance of the free RNA band, as the peptide-RNA complex has an overall
positive charge appearing blurry on the gel (*Data not shown, completed by Snezana
Stefanovic). Two bands were observed for the free Q1-Q2 RNA (data not shown) corresponding
to these two alternative conformations [31], and upon addition of the FMRP RGG, both bands
are shifted indicating the formation of a complex with the FMRP RGG. This result shows that
the Q1 and Q2 GQs within an expanded segment retain the ability to interact with FMRP RGG.
We hypothesized that the role of FMRP is to remodel the PSD-95 mRNA structure by
binding to one or more GQs in which the miR-125a binding site could be exposed/hidden,
regulating the RISC accessibility. Thus, it is possible that the phosphorylated FMRP targets with
higher affinity a GQ in which the miR-125a binding site is exposed and available for binding. To
test this hypothesis, we used fluorescence spectroscopy to measure the affinity of full length
FMRP and its phosphomimic FMRP S500D [87] to the isolated Q11234 and Q2 PSD-95 GQs,
respectively. We expressed and purified FMRP Isoform 1 and its phosphomimic FMRP S500D
and designed two fluorescently labeled RNAs, in which the adenines at position 4162 within
PSD-95 Q11234 and at position 4193 within PSD-95 Q2 were replaced with 2-aminopurine (2AP)
(Fig 8B, adenines 4162 and 4193 are circled). 2AP is a highly fluorescent analog of adenine
whose steady-state fluorescence is sensitive to changes in its microenvironment [73, 74]. Binding
curves were obtained by titrating increments of FMRP or FMRP S500D into a fixed 2-AP
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labeled RNA in 10 mM cacodylic acid buffer, pH 6.5 in 150 mM KCl (Fig 3). 1 µM of bovine
serum albumin (BSA) was added to the RNA samples prior to FMRP titration to prevent nonspecific binding (*Data not shown, completed by Snezana Stefanovic).

Figure 9. (A) Bi-PSD-95 Q1-Q2 pull down of endogenous FMRP and phosphorylated
FMRP. The Bi-PSD-95 Q1-Q2 probe was denatured at 95°C for 5 minutes and cooled at room
temperature for 15 minutes. 5 μM of probe was incubated with E17 mouse brain lysate for 20
minutes at room temperature and NeutrAvidin agarose (Thermo Scientific, Inc.) pre-blocked
with BSA was used to precipitate the probes. After extensive washing, proteins were detected
by immunoblot against FMRP (top panel) and its phosphorylated form P-FMRP (middle
panel). (B) miR-125a was detected by qPCR experiments, in pull-down experiments from E17
mouse brain lysates by using the Bi-PSD-95 Q1-Q2 probe. A control miRNA, miR-134-3p,
was not significantly pulled down by the Bi-PSD-95 Q1-Q2 probe.
The binding dissociation constants (Kd) of the various FMRP-RNA complexes were
determined by fitting the binding curves to equation 4 (chapter 7, materials and methods). All
fluorescence spectroscopy experiments were performed in triplicate, and we report the average
dissociation constant Kd and standard deviation. For both PSD-95 Q11234 and Q2 mRNAs, it is
apparent that the phosphomimic FMRP S500D targets GQs with nearly 2-fold higher affinity (Kd
PSD-95 Q11234 = 66 ± 10 nM, Kd PSD-95 Q2 = 100 ± 17 nM), than FMRP (Kd PSD-95 Q11234 =

23

128 ± 27 nM, Kd PSD-95 Q2 = 195 ± 16 nM). It is interesting to note that the dephosphorylated
FMRP still has high affinity for the Q11234 and Q2 GQs (albeit less than FMRP S500D),
consistent with in vivo data showing that upon its dephosphorylation triggered by synaptic input,
FMRP remains bound to PSD-95 mRNA [44].
To further validate that the PSD-95 mRNA Q1-Q2 GQs are sufficient for the endogenous
FMRP recognition we have performed a series of pull down experiments using a biotin-labeled
PSD-95 Q1-Q2 probe (Bi-PSD-95 Q1-Q2). The probe was incubated with lysates from E17
mouse brain and further precipitated with NeurAvidin agarose. FMRP was identified using
antibodies that recognize both non-phosphorylated and phosphorylated isoforms (Figure 9A, top
panel), while phosphorylated FMRP was identified using P-FMRP specific antibodies (Figure
9A, middle panel) (*Data shown was completed by Kathryn Moss from Dr. Bassell’s lab).
It is apparent that more than one FMRP isoform is pulled down from the brain lysate
(shown as multiple bands in top panel), while only phosphorylated FMRP was recognized using
P-FMRP specific antibody (shown as a single band in middle panel). In a control experiment,
FMRP pull down was probed with a biotinylated HCV derived RNA probe [29, 31] for which
FMRP has no specificity. These findings suggest that the GQs within PSD-95 Q1-Q2 are
sufficient for recognition by both FMRP and phosphorylated FMRP in the presence of other
cellular factors, validating our in vitro fluorescence spectroscopy experiments.
Chapter 3.3 Interactions of FMRP with miR-125a. It has been shown that recombinant FMRP
binds miRNAs derived from Dicer cleavage and can anneal them onto their mRNA targets by
using its KH1 and KH2 domains [88]. Thus, we investigated by EMSA if FMRP and its
phosphomimic FMRP S500D bind to miR-125a. Our results show that at 200 nM RNA
concentrations, only FMRP S500D binds miR-125a (Figure 10A/B), as evidenced by the
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diminishing and respectively disappearance of the free miR-125a band at 1:1 (lane 2) and 1:2
(lane 3) ratios of miRNA: protein. In contrast, under the same conditions, the unphosphorylated
FMRP does not bind miR-125a (Figure 10A). We have also demonstrated that the isolated
FMRP RGG box domain does not bind miR-125a, indicating that this FMRP RNA binding
domain it is not responsible for the recognition between FMRP S500D and miR-125a (Figure
10F). Additionally, the recognition of miR-125a is specific, as an unrelated miRNA miR-122, is
not bound by FMRP S500D (Figure 10E).
The finding that at nM concentrations only the phosphomimic FMRP S500D binds miR125a is novel, and apparently contradicts previous findings that unphosphorylated recombinant
FMRP binds miRNAs [85, 89], however, it is possible that in previous studies much higher ratios
of FMRP to miRNA were used. The FMRP KH1 and KH2 domains are required for binding
miRNA [85]. The KH RNA binding domain binds to single stranded RNA with the preferred
four nucleotide sequence Y(C/A)(A/C)Y, where Y is a pyrimidine [90, 91]. However, there are
exceptions to this rule, as the first KH domain of the polyC binding protein 2 (PCBP2) has been
crystalized in complex with both CCCT/U and ACCC sequences [92] and the third KH domain
of the KSRP protein has been crystalized in complex with the AGGGU sequence [93]. We
analyzed the sequence of miR-125a and determined that it has multiple sites that satisfy the
Y(C/A)(A/C)Y sequence requirement: two overlapping sites within its seed (UCCC- nt 1-4 and
CCCU- nt 2-5) and two additional adjacent sites (CCCU- nt 10-13 and UAAC nt 15-18) (Figure
10G). Typically, a single KH domain recognizes four nucleotides [94, 95], however, tandem KH
domains within the same protein have been shown to recognize longer RNA sequences [96, 97].
The dissociation constants of single KH domains in complex with their RNA targets is in
the low to high micromolar range, whereas those of full length proteins containing tandem KH
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domains are in the low nM range [98]. Our EMSA binding experiments of FMRP S500D were
performed at a fixed 200 nM miR-125a concentration and since the free miR-125a band
disappeared completely in the presence of 400 nM FMRP S500D (Fig 10B, lane 3), we estimated
that the dissociation constant of the FMRP S500D - miR-125a complex is in the low nM range.
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Figure 10. EMSA binding of FMRP, FMRP S500D and FMRP RGG box to miR-125a.
EMSA (15% non-denaturing gel) of miR-125a with FMRP S500D (A). Free 200 nM miR125a (lane 1) was incubated with a 1:1 (lane 2) and 1:2 (lane 3) RNA: FMRP ratio (B) FMRP
S500D (C). FMRP S500D-Mut (D). FMRP S500D-Mut2. (E). EMSA (15% non-denaturing
gel) of an unrelated miRNA, miR-122, with FMRP S500D. Free 200 nM miR-122 (lane 1)
was incubated with a 1:1 (lane 2) and 1:2 (lane 3) RNA: FMRP S500D. (F). miR-125a with
FMRP RGG Box peptide. (G). Finally, free 200 nM miR-125b (lane 1) was incubated with a
1:1 (lane 2) and 1:2 (lane 3) RNA: FMRP S500D ratio. The gels were visualized by staining
with SYBR Gold for 15 minutes. The miR-125a sequence is shown in (H) with the predicted
binding sites for the KH domains highlighted in green; miR-125a-Mut, miR-125a-Mut2 and
miR-125b sequences are also shown for comparison with the differences from miR-125a
highlighted in red.
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This result suggests that FMRP S500D binds miR-125a using more than one KH domain. FMRP
has three KH domains, one non-canonical KH0 domain at its N terminus (amino acids 126-202)
[99] and two canonical KH domains, the KH1 domain (amino acids 216-279) and KH2 domain
(amino acids 281-425). The KH0 domain lacks the canonical GXXG sequence between the two
alpha helices of the KH domain  core and since it has been shown so far that KH domains
lacking this sequence do not show independent nucleic acid binding capability [100], we ruled
out its involvement in miR-125a binding. Both KH1 and KH2 domains have the GXXG
sequence and moreover, it has been shown that they are required for the efficient FMRP
annealing of miRNAs onto their targets [85]. Thus, we hypothesized that the two adjacent sites
CCCU nt 10-13 and UAAC nt 15-18 within miR-125a are the target sites recognized by the KH1
and KH2 domains of FMRP S500D. To test this hypothesis, we rationalized that the elimination
of one of the two sites will greatly reduce the FMRP S500D affinity for miR-125a. Thus, we
mutated nucleotides 17 and 18 from AC to GA, changing the UAAC nt 15-18 site in wild type
miR-125a to UAGA nt 15-18 in the mutated miR-125a (miR-125a-Mut), no longer a recognition
motif for the KH domain (Fig 10C). As seen in Fig 10C, the affinity of FMRP S500D is greatly
diminished for miR-125a-Mut as compared with the wild type miR-125a. We have also
investigated the binding of FMRP S500D to miR-125b, a miRNA belonging to the miR-125
family, which has an identical sequence to miR-125a except it lacks nt 14 and 15 (UU) (Figure
10G). miR-125b will thus present to FMRP S500D either the CCCU nt 10-13 or the UAAC nt
13-16 (equivalent positions 15-18 in miR-125a) binding sites, but not both, since U13 is used in
each of the two binding sites. Surprisingly, the binding affinity of FMRP for miR-125b seems to
be very similar to that for miR-125a (compare Figure 10B and Figure 10G). It is possible that
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one of the binding sites remains UAAC nt 13-16, whereas in miR-125b the second binding site
becomes ACCC nt 9-12. There is precedent for the recognition of the ACCC sequence by the
KH domain, as this sequence has been crystalized in complex with the PCBP2 KH1 domain
[101]. This result suggests that as long as the UAAC nt 13-16 site remains intact, sequence
variations could be tolerated at the second binding site. To further test this hypothesis we
constructed miR-125a-mut2 in which the auxiliary binding site CCCU nt 10-13 was mutated to
CCGU, while leaving the UAAC nt 15-18 binding site intact.

Figure 11. miRNA-125a binding FMRP. EMSA (15% non-denaturing gel) of miR-125a
with FMRP. Free 200 nM miR-125a was incubated with 1:1 (lane 2), 1:2 (lane 3), 1:4 (lane 4),
1:6 (lane 5) ratios of FMRP at room temperature for 15 minutes. The gels were visualized by
staining with SYBR Gold for 15 minutes
As seen in figure 10D the binding of FMRP S500D to miR-125a-mut2 is similar to its
binding to miR-125a and miR-125b, indicating that the UAAC nt 15-18 site is the primary
binding site. However, a second site whose sequence can somewhat vary makes additional
contributions to the binding, since FMRP S500D can still bind miR-125a, albeit with lower
affinity, when the UAAC nt 15-18 is mutated (figure 10C). The finding that the
unphosphorylated FMRP does not bind miR-125a even at RNA: protein ratios up to 1:6 (Figure
11), whereas FMRP S500D’s binding is complete at a RNA: protein ratio of 1:2 is novel. The
only difference between FMRP and FMRP S500D is the replacement of serine at position 500
with aspartic acid, mimicking its phosphorylation, and S500 is not located within the KH1 or
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KH2 domains. It is possible that the protein dephosphorylation either induces major structural
changes within its KH1 and KH2 domains, or induces a change in the arrangement of the FMRP
domains with respect to each other that might block the ability of one or both its KH1 and KH2
domains to bind RNA.
Thus, we investigated if the S500D mutation causes major structural changes within
FMRP by circular dichroism spectroscopy and by fluorescence spectroscopy, monitoring the
FMRP intrinsic tryptophan fluorescence. We used FMRP and FMRP S500D at 1 M and 5 M
concentrations, as it has been proposed that at high M concentrations FMRP tends to aggregate
[102]. As seen in Figure 12A there are no major structural differences between FMRP and
FMRP S500D, as both their CD spectra overlap almost perfectly at both protein concentrations
investigated.
In the fluorescence spectroscopy experiments we monitored the intrinsic fluorescence
of the FMRP tryptophan residues, the observed fluorescence signal being an average value of the
five tryptophan amino acids present in FMRP: W36, W79, W80, W395, W513. The first three
tryptophans are located in the FMRP N terminal domain that contains two tandem Agenet 1 and
Agenet 2 domains and its KH0 domain [96]. W395 is located in the KH2 domain variable loop,
whereas W513 is located 13 amino acids from the S500 phosphorylation site and 19 amino acids
from position 532, the beginning of the RGG box, most likely in an unstructured region. As seen
in Figure 12, the average tryptophan fluorescence spectra of FMRP and FMRP S500D are almost
identical, consistent with the absence of major structural changes of the protein upon its
dephosphorylation.
The crystal structure of the linked FMRP KH1 and KH2 domains reveals that there is no
extensive contact between the domains, which are connected by a single amino acid, Glu280
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[93]. It is possible that the two domains bind RNA independently of each other, and subtle
protein conformation changes induced by phosphorylation could affect one domain or both. The
S500 position is in close proximity to the FMRP RGG box that binds GQ structures and our
results show that although FMRP and FMRP S500D have an identical RGG box, they have
different affinities for the Q1234 and Q2 GQs (data not shown). Thus, we speculate that the FMRP
phosphorylation might affect the arrangement of the RGG box with respect to the KH1 and/or
KH2 domains, in a conformation that allows both, the RGG box to bind with higher affinity to
GQ structures and the KH1 and KH2 domains to both bind miR-125a.
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Figure 12. Biophysical characterization of FMRP and FMRP S500D. (A) CD spectra for
FMRP and FMRP S500D were acquired at concentrations of 1 µM and 5 µM, respectively. (B)
Fluorescence spectroscopy was used to monitor the tryptophan fluorescence of FMRP and
FMRP S500D at 1 µM and 5 µM concentrations.
Since the FMRP RGG box is unstructured in the absence of RNA, such a conformational change
will not necessarily be apparent in CD spectral differences between FMRP and FMRP S500D.
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Moreover, since both W395 and W513 are in unstructured regions, they might also not be able to
report on the arrangements of the FMRP domains with respect to each other. Further work is
required to elucidate how the FMRP phosphorylation allows the protein to bind with high
affinity to both miR-125a and the PSD-95 GQ structures, whereas upon its dephosphorylation its
affinity for miR-125a is completely abolished whereas that for the GQ structures is reduced
almost in half.
Chapter 3.4 miR-125a binding to PSD-95 mRNA in the presence of FMRP and FMRP
S500D. In our previous study [31] we have shown that at micromolar RNA concentrations miR125a binds to its target within PSD-95 mRNA, without the disruption of the GQ structures
formed in Q1-Q2 and that the FMRP RGG box domain peptide did not affect this binding.
However, the full-length FMRP contains the additional KH1 and KH2 RNA binding domains
that we showed bind to miRNA-125a and thus, might play a role in the binding of miR-125a to
its target sequence within PSD-95 mRNA. To asses such a role we performed EMSA binding
experiments in conditions less optimal for binding, at nanomolar RNA concentrations and
reduced incubation time. The binding of miR-125a to PSD-95 Q1-Q2 was tested in the absence
and presence of FMRP and FMRP S500D (Figure 14) in two different conditions: in 25 mM KCl
and in 25 mM LiCl. The K+ ions stabilize GQ structures and we have shown previously [31] that
in 25 mM KCl both Q1 and Q2 quadruplexes are folded. In contrast, we determined by UV
thermal denaturation that in 25 mM LiCl the Q1 GQ is unfolded, whereas the Q2 GQ remains
folded (Figure 13). Thus, in 25 mM LiCl the miR-125a binding site on PSD-95 Q1-Q2 is fully
exposed, whereas in 25 mM KCl Q1-Q2 exists in two alternate conformations both of which
have the Q1 and Q2 GQs folded, making the miR-125a seed binding site exposed in the linker
between Q1 and Q2, but the rest of the binding site inaccessible [31].
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Figure 13. PSD-95 Q1-Q2 Thermal denaturation in the presence of 25 mM LiCl. UV/Vis
spectroscopy was used to observe the melting profile of the PSD-95 Q1-Q2 to show that
without KCl there is only one hypochromic transition because Q1 will not fold without
potassium.
In 25 mM KCl at 200 nM RNA concentration PSD-95 Q1-Q2 exists in two conformations as
evidenced by two distinct main bands (Fig. 14A, lane 1). Additionally, two very faint upper
bands are present in lane 1, that we attribute to the stacking of two PSD-95 Q1-Q2 molecules,
stabilized by K+ ions [31]. Upon the incubation of PSD-95 Q1-Q2 with miR-125a for 15 minutes
in the absence of FMRP, a very faint band appears at a higher molecular weight (Fig. 14A, lane
3, arrow), indicating the formation of the miR-125a-PSD-95 Q1-Q2 complex; however, most of
the PSD-95 Q1-Q2 and miR-125a remain unbound. To test if FMRP or FMRP S500D have
chaperone activity with respect to the binding of miR-125a on PSD-95 Q1-Q2, we have
incubated them in the presence of the respective protein for 15 minutes, followed by treatment
with proteinase K to digest FMRP or FMRP S500D, prior to running the samples on the gel [85].
The band corresponding to the miR-125a-PSD-95 Q1-Q2 complex has the same intensity in the
absence or presence of the respective protein (compare Fig. 14A, lanes 3, 4 and 5), indicating
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that neither FMRP (lane 4), nor FMRP S500D (lane 5) have nucleic acid chaperone activity, as
they do not stably anneal miR-125a upon its PSD-95 Q1-Q2 target. This result is in contrast to a
previous report showing that FMRP has the ability to anneal miRNAs upon their RNA targets
[85]; however, in that case the miRNA target site was not embedded into a GQ forming region.
To determine if the folding of the Q1 quadruplex has any effect upon the FMRP nucleic
chaperone activity, we repeated the above experiments in the presence of 25 mM LiCl. In 25 mM
LiCl at 200 nM RNA concentration PSD-95 Q1-Q2 exists mainly in a single conformation (Fig.
14B, lane 1), whereas upon its incubation with miR-125a for 15 minutes in the absence of FMRP

Figure 14. EMSA binding of PSD-95 Q1-Q2 and miR-125a in the presence of FMRP. (A)
EMSA (15% non-denaturing gel) of PSD-95 Q1-Q2 mRNA with miR-125a in 25 mM KCl
(A). 200 nM mRNA and miRNA (lanes 1 and 2) were incubated together (lane 3) or incubated
with 400 nM FMRP or FMRP S500D (lanes 4 and 5). Following this incubation, proteinase K
was added to digest FMRP and FMRP S500D prior to running the samples on the gel. (B)
Identical conditions as described in (A) were used, except in the presence of 25 mM LiCl.
(Fig. 14B, lane 3) a complex is formed as evidenced by the apparition of a shifted upper band
with the concomitant complete disappearance of the free miR-125a band (compare Fig. 14B,
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lanes 2 and 3). Moreover, a thin band is visible at a much higher molecular weight, which we
attribute to the binding of two miR-125a molecules to PSD-95 Q1-Q2, as when the Q1 GQ is
unfolded there are two binding sites complementary to the miR-125a seed sequence. FMRP (Fig.
14B, lane 4) or FMRP S500D (Fig. 14B, lane 5) do not make any difference with respect to the
formation of the miR-125a-PSD-95 Q1-Q2 complex, however, such an effect would be hard to
detect in these conditions, given that even in the absence of the protein miR-125a binds so
efficiently to PSD-95 Q1-Q2 when the Q1 GQ is unfolded.
Our experiments do not support the hypothesis that FMRP and/or FMRP S500D have
nucleic acid chaperone activity with respect to the binding of miR-125a to PSD-95 Q1-Q2, as in
such a case the miR-125a-PSD-95 Q1-Q2 complex should be stable even after the protein
digestion by proteinase K. However, it is possible that the presence of FMRP and/or FMRP
S500D is required for the formation of a stable miR-125a-PSD-95 Q1-Q2 complex in cellular
conditions. To test if miR-125a binds to the PSD-95 Q1-Q2 RNA probe in the presence of
endogenous FMRP we performed real-time quantitative polymerase chain reaction (qPCR) on
the pull-downs using the Bi-PSD-95 Q1-Q2 probe with the E17 mouse brain lysates. As seen in
figure 4B middle bar, the Bi-PSD-95 Q1-Q2 probe which pulled down FMRP and FMRP S500D
(Figure 9A) also showed a significant pull down of miR-125a from the brain lysates in
comparison to a control miRNA, miR-124-3p. These results show that the miR-125a
complementary sequence within PSD-95 Q1-Q2 is available for binding, suggesting that the
favored GQ conformations within the probe is one in which the miR-125a site is exposed and
moreover, that FMRP and/or FMRP S500D is also present in the miR-125a-PSD-95 Q1-Q2
complex. Our in vitro data indicates that only FMRP S500D and not FMRP binds miR-125a
(Figure 10A and 10B), suggesting that the pulled down miR-125a from the E17 brain lysates is
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likely in complex with FMRP S500D. However, based solely on these experiments that used the
Bi-PSD-95 Q1-Q2 probe for pull down we cannot rule out the possibility that FMRP is also
forming complexes with miR-125a and PSD-95 Q1-Q2 in brain lysates.
Chapter 3.5 miR-125a-mediated PSD-95 mRNA translation regulation is FMRP
phosphorylation state dependent. In this study we have shown that both FMRP ISO1 and its
phosphomimic, FMRP S500D bind to the PSD-95 Q1 and Q2 GQs with high affinity and
specificity in vitro, with the phosphomimic targeting both structures with greater affinity than the
unphosphorylated protein. The dissociation constants, Kd PSD-95 Q11234 = 66 ± 10 nM and Kd
PSD-95 Q2 = 100 ± 17 nM for binding with FMRP S500D and Kd PSD-95 Q11234 = 128 ± 27
nM and Kd PSD-95 Q2 = 195 ± 16 nM for binding with FMRP, are the first reported binding
values of FMRP to PSD-95 mRNA. We have previously reported that FMRP binds with high
affinity to GQ structures formed within Shank1 mRNA [29], NR2B mRNA [31] and its own
encoding Fmr1 mRNA, additional targets of the protein [75]. Interestingly, for NR2B mRNA
and one of the Shank1 mRNA GQs a similar trend was observed where the affinity of FMRP
S500D was higher, whereas there was no difference in affinity for the binding of FMRP and
FMRP S500D for its own mRNA. This difference might be related to the function of FMRP with
respect to the particular mRNA, as FMRP is involved in the translation regulation of PSD-95,
Shank1 and NR2B mRNAs, whereas in the case of Fmr1 mRNA, FMRP is involved in its
alternative splicing to affect the production of the isoforms ISO1, ISO2 and ISO3 [103].
Additionally, we have shown that the isolated PSD-95 Q1-Q2 GQs are sufficient for the
recognition of various isoforms of FMRP found within mouse brain lysates, including the
phosphorylated FMRP (P-FMRP) (Figure 9A), in agreement with our in vitro findings that both
the unphosphorylated and phosphorylated FMRP target the GQ structures. Moreover, the
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structures adopted by these GQs allow miR-125a to recognize its binding site, both in vitro
(Figure 14) and in mouse brain lysates (Figure 9B).
Interestingly, we found that the FMRP-phosphomimic S500D binds to miR-125a (Figure
10A), whereas the unphosphoryated protein does not (Figure 10A), even at high protein: RNA
concentrations (Figure 11). This is a novel finding, as previously it has been shown that
phosphorylated FMRP associates with pre-miRNAs [86], and that FMRP can anneal mature
miRNAs onto their mRNA targets [85], but not that depending on its phosphorylation status
FMRP could function as a switch in binding mature miRNAs. The binding of miR-125a is
specific, as an unrelated miRNA, miR-122, is not bound by FMRP S500D (Figure 10E). The
FMRP RGG box is not involved in miR-125a binding (Figure 10F) and we proposed that FMRP
S500D uses its KH1 or KH2 domains to bind the UAAC site within miR-125a which is a
canonical recognition site for the KH domain RNA binding motif. A mutant miR-125a in which
the UAAC site is disrupted, is still bound by FMRP S500D, albeit with much lower affinity
(Figure 10C), supporting the idea that the protein binds multiple sites on miR-125a. However,
another mutant where the secondary binding site, CCCU, is disrupted still maintains high
binding similar to the miR-125a wt. Suggesting that the UAAC is the primary binding site for the
KH domain.
Given that the FMRP phosphorylation confers its ability to bind miR-125a, we
investigated if this posttranslational modification induces major secondary structure changes of
the protein. Thus, we have used CD spectroscopy and fluorescence spectroscopy to compare for
the first time the spectra of full-length FMRP and FMRP S500D, our results indicating that there
are no major structural changes between FMRP and its phosphomimic (Figure 12A and 12B).
Based on our findings, we postulate that the FMRP phosphorylation induces rearrangements of
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both the KH1 and KH2 domains and of its RGG box with respect to each other that allow the
RGG box to bind with higher affinity the PSD-95 Q1 and Q2 structures, and position the KH
domains in the right orientation to optimally bind miR-125a (Figure 10A).
There is evidence in the literature showing a link between FMRP and the miRNA
pathway, namely that there are interactions between the mammalian FMRP and miRNAs and
components of their pathway, such as Dicer and AGO2, which are all elements of RISC [104].
Muddashetty et al. have shown that there is significantly reduced miR-125a localization to
dendrites and synapses in the mice lacking FMRP, explaining this as the inability of AGO2 and
miR-125a guided RISC to assemble on PSD-95 mRNA [44]. Moreover, in the presence of
phosphorylated FMRP the miR-125a-guided RISC mediates the PSD-95 translation repression,
whereas upon the FMRP dephosphorylation, induced by DHPG, the PSD-95 translation is derepressed. However, the molecular mechanisms by which this regulation is accomplished are not
known.
Similar to the role of FMRP in mediating the miR-125a translational repressor function
on PSD-95 mRNA, it has been shown that the phosphorylation status of FMRP is critical in the
regulatory function of FMRP, with respect to the miR-196a-mediated repression of HOXB8
mRNA [105]. This study proposed that that FMRP directly interacts with AGO2, via binding to a
specific binding pocket in the MID domain of the AGO2 and that phosphorylated FMRP recruits
RISC to specific mRNA targets containing either GQs or U-rich sequences via its interactions
with the RISC component AGO2 [102]. However, this simplified model fails to account how
does FMRP discriminate for the RISC containing the correct miRNA targeting the mRNA to
which FMRP is bound. Previous studies determined that there is selectivity in the association of
mouse brain miRNAs with FMRP [106], and this cannot be explained simply by the recognition
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of AGO2 by the phosphorylated FMRP, as this RISC component is common to all miRNAguided RISCs.
Our novel findings that FMRP S500D binds the isolated miR-125a, in the absence of
AGO2, whereas the unphosphorylated FMRP does not, could explain the selective recognition
by the phosphorylated FMRP of the correct miR-125a guided RISC. Thus, we propose a refined
model (Figure 15) according to which the phosphorylated FMRP facilitates the binding of the
miR-125a-guided RISC to PSD-95 mRNA by using its KH1 and KH2 domains to recognize the
CCCU nt 10-13 and UAAC nt 15-18 sites within miR-125a, and potentially also binding to
AGO2 [102], as well as by using its RGG box to bind the Q1 and Q2 GQs. The model does not
distinguish if the phosphorylated FMRP binds first PSD-95 mRNA via GQ recognition and then
recruits miR-125a-RISC or if the pre-formed miR-125a-RISC-phosphorylated FMRP complex
recognizes PSD-95 mRNA via miR-125a binding to its target site and FMRP binding to the GQ
structures. We propose that the role of the phosphorylated FMRP in this context is to allow for
the formation of a stable complex between the miR-125a-guided RISC and its target PSD-95
mRNA. The miR-125a seed does not have a perfectly complementary target sequence on PSD95 mRNA, as it could either form a GU base pair (Figure 15A, top) or contain a bulged G
(Figure 15A, bottom). Note that although the guide miR-125a nt at position 1 (g1), U, is
complementary to the corresponding target position 1 (t1), A, on PSD-95 mRNA, this base pair
does not form in the presence of AGO2. Crystal structures of AGO2, bound to miRNA and to the
miRNA-target duplex showed that g1, which is in many cases U, is buried within a pocked in the
AGO2 MID domain, unavailable for binding [107], whereas t1 on the target, which is in many
cases A, inserts into a narrow pocket formed between the AGO2 MID and L2 domains [108].
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Figure 15. Proposed model for FMRP/ FMRP S500D in mediating the miR-125a
translation regulation of PSD-95 mRNA. (A). Predicted binding of miR-125a to PSD-95
mRNA. The PSD-95 mRNA sequence complementary to the miR-125a seed is highlighted in
blue; the G-U base pair or the G-bulge predicted to form upon the miR-125a seed binding to its
target onto PSD-95 mRNA is highlighted in red. The proposed sites onto miR-125a bound by
the KH domains of FMRP S500D are shown in green. (B). Due to the presence of a weak
binding between the miR-125a seed and its target sequence we predict that FMRP S500D
associates with miR-125a and potentially with Ago2 within RISC to confer additional
interactions that stabilize the RISC-PSD-95 mRNA complex, inhibiting the PSD-95 mRNA
translation. Upon the FMRP dephosphorylation induced by synaptic input, miR-125a bound
RISC dissociates and PSD-95 translation is reactivated.
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It has been shown that seed sequences containing a single GU base pair with the mRNA
target can be functional in vivo in the context of a 7-mer seed, however their translation
repression efficiency is low [109]. For example, a GU wobble base pair in the context of an
miRNA seed-target pairing is detrimental to the miRNA translation repression, reducing its
efficiency by 16 fold, despite the fact that this pairing was not predicted to reduce the stability of
the miRNA: mRNA interaction [110].
A series of crystal structures of the miRNA-loaded AGO2 bound to an 11 nt mRNA target
containing complementary sequences to the miRNA nucleotides g2-g7 (6-mer seed), g2-g8 (7mer seed) and g2-g9 (8-mer seed) [105] revealed that the primary mode of interaction of AGO2
is through the shape complementary recognition of the minor groove formed by the miRNA
seed-target RNA duplex. Extensive hydrophobic and van der Waals contacts were observed
between AGO2 and nts 2 to 7 of the miRNA-target RNA duplex [105], potentially explaining
why the GU wobble base pair within nts 2 to 7 of the miRNA-target RNA duplex is so
detrimental to translation repression efficiency, as this base pair structurally perturbs the minor
groove of a canonical A type helix [111], reducing the AGO2 binding affinity.
The translation repression function of miRNA seed-target pairings containing bulged
nucleotides in either the seed or the mRNA is also negatively impacted, only some of such
miRNAs being functional in vivo, especially those supported by extensive complementarity
between the miRNA 3’-end and the mRNA target [106].
It has been shown that single or double nucleotide seed mismatches have a negative
impact reducing the kon of the RISC binding to an mRNA target by 6-10 fold, especially when
they occur at positions g2-g6 [112]. However, seed mismatches affect most drastically the koff
rate, as RISC has been shown to dissociate from mismatched targets 70-3200 faster than from
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perfectly matched seed-targets, again with mismatches at g2-g6 positions having the most impact
[109]. While 3’ supplemental base pairing beyond the seed sequence does not increase the
stability of the RISC-target complex in the case of a perfectly matched 7-mer strong seed, in the
case of a weaker AU-rich seed the additional 3’ supplemental base pairing slowed more than 7fold the RISC dissociation [109]. This suggests that although the mRNA target recognition is
primarily dictated by the seed recognition, in the case of weaker or 1-2 nt mismatched seeds,
complementarity to the center and 3’ end of the miRNA could compensate, resulting in the
formation of a stable RISC-mRNA target complex [109].
The comparison of the crystal structures of AGO2-guide and AGO2-guide-target duplex
[105] reveals rearrangements in both, the protein and the miRNA, organizing the guide nts g11g16 to adopt an almost A type conformation with their Watson-Crick faces exposed to the
solvent, able to form additional base pairs with the target RNA, thus contributing to the stability
of the miRNA-target mRNA complex. The miRNA guide nts 17-19 appear to be
conformationally heterogeneous, their role in formation of supplemental miRNA-mRNA base
pairs being unclear.
In the case of miR-125a, the formation of supplemental base pairs beyond the seed
sequence with PSD-95 mRNA is not possible, since the complementary bases for the guide past
nt 8 are buried within the Q1 GQ (Figure 8A), and thus not available for binding. Given that
miR-125a does not have a perfectly matched 7-mer seed, forming either a GU wobble or a
bulged G in the seed-target pairing (Figure 15A), and that it cannot form any 3’ supplemental
base pairs with PSD-95 mRNA, we predict that in the absence of other factors, it will not form a
stable RISC-PSD-95 mRNA complex, likely due to an increased dissociation rate koff. This
prediction is supported by our findings that when the PSD-95 Q1 GQ is folded (in the presence
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of KCl), preventing any 3’ supplemental base pairing beyond the seed between miR-125a and its
target, only a small fraction of miR-125a is stably complexed with PSD-95 Q1-Q2 mRNA (Fig.
14A). In contrast, when the PSD-95 Q1 GQ is unfolded (in the presence of LiCl) and the entire
miR-125a binding site is exposed, miR-125a forms a stable complex with PSD-95 Q1-Q2
mRNA (Figure 14B) at nM concentrations.
We propose that the role of phosphorylated FMRP is to increase the stability of the miR125a-RISC-PSD-95 mRNA complex by binding to the miR-125a nt 10-13 and 15-18 and
potentially to AGO2 [102], thus, substituting for the miRNA-mRNA 3’ supplemental base
pairing (Figure 15B, middle). When FMRP is dephosphorylated in response to synaptic input, it
can no longer bind to miR-125a (Figure 10B and Figure 11) and AGO2 [102], leading to the
destabilization of the miR-125a-RISC-PSD-95 mRNA complex and resulting in the translation
de-repression of PSD-95 mRNA (Fig. 8B bottom).
The helicase MOV10 has been shown to also bind GQ structures and when bound to G
rich sequences in the presence of FMRP to prevent the RISC association [113]. Thus, MOV10
might interact with the unphosphorylated FMRP to prevent the re-association of RISC.
According to our model, the formation of a functional miR-125a-guided RISC complex onto
PSD-95 mRNA requires the presence of phosphorylated FMRP. This is supported by our EMSA
binding experiments showing that when FMRP (unphosphorylated or S500D) was digested by
proteinase K, following its incubation with miR-125a and PSD-95 Q1-Q2 mRNA, the same
fraction of miR-125a was complexed with PSD-95 Q1-Q2 mRNA (Fig 14A). Thus, in the case
of this miRNA that does not have the possibility of forming 3’ supplemental base pairs beyond
the seed with its mRNA target, FMRP does not have nucleic acid chaperone activity.
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Such an elegant design has the advantage that the miR-125a-mediated PSD-95 mRNA
translation regulation is reversible being turned on/off by using as a switch the
dephosphorylated/ phosphorylated FMRP. This work provides for the first time a mechanistic
model explaining the role of FMRP in facilitating the miR-125a translation regulation of PSD-95
mRNA and should spark further research to determine if such a switch involving the interactions
of phosphorylated FMRP with miRNA to increase the stability of the RISC-mRNA target is
unique to miR-125a or if it also exists for other miRNAs whose translation regulation function is
mediated by FMRP.
Chapter 4: GQ formation in the 3’-UTR of BDNF regulates alternative polyadenylation
Chapter 4.1 GQ structure and its potential role in alternative polyadenylation.
Polyadenylation is a very important mRNA 3’-end modification that can affect the way the
transcript is spliced, and ultimately the transcript length, as well as its translation [114]. The
cleavage and polyadenylation specificity factor (CPSF) [115] is part of a multi-protein complex
that interacts with a specific sequence, the poly(A) site (canonically 5’-AAUAAA-3’), within the
pre-mRNA and initiates the cleavage and polyadenylation processing [116, 117]. The mechanism
of cleavage and polyadenylation has been shown to be significant for health and disease [118,
119]. Different polyadenylation patterns can affect the transcript length, which will in turn affect
how it is translated, and ultimately determine the levels of expressed protein.
Alternative polyadenylation (APA) can occur when there are multiple poly(A) sites within the
transcript [120]. and more than 50% of human genes are known to have APA sites [121]. There
are various factors that impact which poly(A) site is processed and this creates a dynamic and
intricate system of regulation for poly(A) site selection [122, 123]. Although APA has been
observed using high-throughput sequencing, the exact factors that are regulating poly(A) site
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selection are still not fully understood [124, 125]. The choice of one poly(A) site over another
poly(A) site is biologically relevant because the site chosen will affect the translation and errors
could potentially lead to disease.
There are two categories of APA: coding region (CR)-APA, which leads to distinct protein
isoforms, and untranslated region (UTR)-APA, which modulates the length of the 3’ UTR in the
transcript [126, 127]. In the case of UTR-APA, the 3’ UTR can be truncated and still maintain
the same coding region, thus expressing the same protein. Since the 3’ UTR of mRNAs contain
RBPs and miRNAs binding sites their shortening, and loss of these regulatory sites, can lead to
changes in mRNA stability, localization, and protein translation efficiency [128].
The choice of poly(A) site could be regulated by many factors. RNA-binding proteins are a
common regulator of many different systems such as cellular metabolism, coordinating
maturation, transport, stability and degradation of all classes of RNAs [129]. These proteins can
directly target the RNA using recognition elements such as RNA sequence motifs present in the
target RNA [130]. It follows that depending on the poly(A) site chosen, the transcript will be
modified and these recognition motifs may be lost, leading to a loss of regulation (Figure 16).

Figure 16. Schematic of alternative polyadenylation. Representative transcript showing two
poly(A) sites in the 3’-UTR and how the length of the transcript is altered depending on which
site is processed.
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A study in 2013 by Beaudoin et al shows promising data that the GQ structure is potentially
involved in 3’ UTR shortening and APA [131]. These authors have shown that over 100 mRNAs
have GQ structures near (within 100 nucleotides) of APA sites. However, they admit this is
likely an underestimation due to the fact that there are many divergent PA signals (other than the
putative AAUAAA); and the distance to the GQ can be extended beyond 100 nucleotides
because previous studies show GQ interactions are relevant even at farther distances (440
nucleotides) [132]. This study demonstrated that in the case of the MCR1 gene the GQ structure
affected the poly(A) site used, however the mechanism by which this is accomplished is unclear.
It is possible that the presence of GQ structure in the 3’-UTR can act as an enhancer for APA
sites that would not be ordinarily processed. Further reports in the literature point towards this
mechanism; GQ was shown to increase poly(A) site recognition by interacting with hnRNP H/F
[133]. Additionally, 3’-UTR GQs present in LRP5 and FXR1 mRNAs lead to APA and as a
result increase the production of transcripts with short 3’-UTRs [129].
Chapter 4.2 The i-motif. The involvement of the GQ structure in the regulation of APA site
choice could be at the DNA level, at the RNA level, or both. If a GQ structure is predicted to
form within the mRNA, it is encoded by a G-rich sequence in the DNA that can also form a
DNA GQ structure. This G-rich DNA sequence has a complementary C-rich sequence that might
form another noncanonical structure named an i-motif (Figure 17).
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Figure 17. Schematic of i-motif structure. The left shows a C+-C base pair. The C+-C base
pair is dependent on the protonated imino (circled in red) in the middle and thus, is pH
dependent. The right panel shows an representative model of an i-motif.
The i-motif is a structure that forms in C-rich DNA sequences that have cytidine stretches
forming a parallel-stranded duplex with protonated C-C base pairs [134]. Formation of the C+-C
base pair is pH dependent since it requires a protonated cytidine, which can only happen at acid
or neutral pH [135]. These structures have been studied in a similar fashion to GQ structure and
have been implicated in the same types of systems. For instance, the BCL2 promoter has been
shown to have an i-motif structure that may be involved in gene regulation by binding with an
hnRNP transcription factor [136]. Both GQ and i-motif structures are capable of destabilizing
adjacent duplex DNA [137]. Thus, the presence of these DNA structures in the proximity of an
APA site might directly influence transcription and contribute to the selection of a specific APA
site. Similarly, the GQ structure formed by the mRNA might interact with regulatory factors,
such as RBPs or miRNA, to influence the APA site selection.
Chapter 4.3 BDNF Introduction. In this study, we selected the brain-derived neurotropic factor
(BDNF) gene to analyze potential effects of a DNA GQ structure upon the choice of an APA
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site, as we performed a bioinformatics study using QGRS mapper [60] that predicted the
existence of a GQ structure in the 3’-UTR of the BDNF gene 200 nucleotides from its APA site.
The BDNF protein plays a vital role in helping regulate brain functions such as neuronal survival
and neuroplasticity [138]. More importantly, a dysregulation in the BDNF expression has been
increasingly linked to psychiatric disorders and neurological degeneration [139]. Changes in the
expression of BDNF have been related to depression, anxiety, and other mental disorders;
additionally, these studies show that not only is the expression of BDNF altered but so is its
function [140,141]. The BDNF gene has been extensively characterized and it was found that
alternative promoters and splicing mechanisms can generate different BDNF transcripts that all
encode for the same BDNF protein [142]. Beyond that, each of these transcripts can have a long
or short 3’-UTR [143]. This is due to APA sites that generate either the short (0.35 kb) or long
(2.85 kb) 3’-UTRs [144]. The long and short transcript variants have different cellular
localizations, with the short being contained to the soma while the long 3’-UTR BDNF mRNA
being also found in the dendrites [145]. Individuals in which the ratio of long to short BDNF
mRNA 3’-UTR is perturbed have been shown to have impaired mental functioning leading to
neurodegenerative diseases [146]. Studies show that the long 3’ UTR transcript is the only
transcript in dendritic sites and that knocking down the long 3’-UTR BDNF leads to mental
impairment associated with neurodegenerative disease symptoms [147]. Given how tightly the
ratio of short versus long 3’-UTR transcript is regulated, it is important to understand the
mechanisms by which the APA site is chosen in the case of BDNF mRNA. Regarding BDNF,
the long 3’UTR suppresses BDNF translation in cis and mediates activity-dependent translation
de-repression of BDNF, which could occur in the soma and in the dendrites [148].
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Our guiding hypothesis is that alternative DNA secondary structures will affect the poly(A)
site used in mRNA processing, thus leading to unique transcripts of varying lengths with
potentially different biological roles. Our biophysical studies show that the G-rich sequence in
the close proximity of the BDNF APA site forms a DNA GQ structure, whereas the
complementary C-rich sequence forms an i-motif. Moreover, we have determined through ChIP
that the presence of the GQ and/or i-motif structures affects the association of RNA Pol II with
BDNF DNA and that mutations leading to the disruption of these structures change the ratio of
long versus short 3’-UTR BDNF transcripts.
This is the first study showing that a GQ structure/and or i-motif in BDNF DNA affects the
choice of an APA site. Since the formation of a GQ structure adjacent to an APA sites is not
limited to the BDNF gene our study opens the door to further studies in this area to determine if
this is a common mechanism for neuronal mRNA APA site selection.
Chapter 4.4 G-rich BDNF DNA forms GQ structure. The QGRS mapper software [60] was
utilized to analyze the BDNF gene to identify the G-rich segments that have the most potential to
form GQ structures in the 3’-UTR. The 20-nucleotide sequence investigated in this study has a
G-score of 40 indicating that it has high potential to form a GQ. Of all the G-rich regions
predicted to form GQ structures, a 20-nucleotide sequence was selected due to its proximity to an
alternative polyadenylation signal in the 3’-UTR of the BDNF gene. The G-rich BDNF sequence
investigated is shown in table 3, the underlined G’s indicate the guanines predicted to form the
GQ.
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Table 3. Sequences used in the BDNF project.

1

H NMR spectroscopy studies were performed to investigate if the G-rich BDNF DNA

can adopt a GQ structure, by monitoring the changes in the imino proton region (between 10 and
15 ppm) upon titration of K+ ions, which stabilize the GQ. The 1H NMR spectra in figure 18
show the imino proton resonance region changes as KCl was titrated in the G-rich BDNF DNA.
In the absence of potassium the resonances in the area between 10-12 ppm, corresponding to the
GQ imino protons, have very low intensity, but upon the addition of KCl they become clearly
visible, indicating the formation of a GQ structure stabilized by K+ ions [61, 62].
The resonance at 13.2 ppm, which appears only upon the formation of the GQ, is
attributed to a canonical Watson-Crick (A-T) base pair, potentially from loop-loop interactions,
as such
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Figure 18. G-rich BDNF DNA 1H NMR. KCl titration showing the increasing stabilization
of the DNA GQ. Bottom spectra is the mutation.
interactions have been reported in previous GQ structures. [68]. The bottom spectrum is the Grich BDNF mutant sequence used to show the successful disruption of the GQ sequence by
interrupting the G-tracts. Clearly, the cluster of imino resonances for the GQ structure between
11-12 ppm disappear for the mutation sequence, whereas resonances between 12-14 ppm,
corresponding to the Watson-Crick base pairs, are present, thus indicating the formation of a
hairpin structure in the G-rich BDNF Mutant DNA.
Circular dichroism spectroscopy studies were performed to investigate the folding of the
GQ formed by the G-rich BDNF DNA [66, 67]. The CD spectra in figure 19 shows the GQ
formed is parallel in nature due to the GQ signatures seen from the observed negative band at
240 nm and the positive band at 265 nm [69, 70]. Additionally, a positive band appears at ~288
nm which is also attributed to loop-loop interactions [149]. These results are consistent with the

52

1

H NMR data, indicating the formation of a GQ structure that has sloop-loop interactions, only in

Figure 19. G-rich BDNF DNA CD spectroscopy. CD spectra of BDNF G-rich DNA in the
presence of increasing KCl concentrations.
the presence of K+ ions.

The stability of the GQ formed by the G-rich BDNF DNA in 150 mM KCl was determined by
measuring its melting temperature (Tm) by UV thermal-denaturation at 295 nm, wavelength
sensitive to GQ dissociation [64]. A hypochromic transition was observed, the midpoint of this
transition indicates the Tm of the structure and was observed at 76 °C. This was repeated at
various DNA concentrations from 5-40 µM. As seen in figure 20, the Tm is independent of the
DNA concentration, indicating the formation of an intramolecular GQ [65]. In conclusion, our
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1

H NMR, CD and UV-Vis spectroscopy results indicate that the G rich BDNF DNA folds into a

parallel, intramolecular GQ structure stabilized by K+ ions (figure 20A).

Figure 20. BDNF DNA UV/Vis spectroscopy. The thermal denaturation profile of the G-rich
BDNF DNA GQ from 5-40 µM concentration and the lack of change in Tm.
Chapter 4.5 C-rich BDNF DNA forms i-motif structure. The complementary sequence to the
BDNF G rich sequence is C rich (shown in table 3). Given that the G rich sequence could fold
into a GQ structure, which would result in a single stranded complementary C rich sequence, we
inquired if this C rich complementary sequence could adopt an i-motif structure. Thus, we
performed 1H NMR spectroscopy studies of the C-rich BDNF DNA. This was achieved by
monitoring the cytidine imino proton resonances between 15-16 ppm, which are characteristic of
the i-motif structure [150]. Since the i-motif structure is pH dependent, we initially performed
these studies at pH 4.0, at which the cytosine is protonated, allowing for the formation of C-C
base pairs. As seen in figure 21 a broad resonance centered around 15.4 ppm is present in the
spectrum of the C rich BDNF DNA in 10 mM cacodylic acid at pH 4.0, indicating the formation
of an i-motif structure. The 1H NMR spectra in figure 21 show that the i-motif structure still
forms at pH 6.5 and is further stabilized at pH 4.0. The resonance at pH 4.0 is much sharper as
the low pH environments stabilize the i-motif, because it requires protonated cytosine’s to form
C-C base pairs
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Figure 21. C-Rich BDNF DNA 1H NMR spectroscopy. Imino proton resonance region of
the wild type C rich BDNF DNA (at pH 4.0 and 6.5) and its mutant in which Cs are mutated to
disrupt the i-motif formation (pH 6.5). The resonances centered around 15.4 ppm are
indicative of i-motif formation.
for the structure to fold [151]. The finding that the C rich BDNF DNA i-motif structure is stable
even at is pH 6.4, this is not unprecedented, as such structures have been previously reported to
form at pH 6.5 [152].
To further confirm the formation of the i-motif in the C-rich BDNF DNA, we performed CD
spectroscopy studies. The CD spectra of C-rich BDNF, in figure 22, shows the signature positive
band at 290 nm and negative band at 260 nm at pH 4.0 which is consistent with the 1H NMR
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data [153]. As the pH of the sample was increased the intensity of the bands decrease and their
maxima shift, indicating destabilization of the i-motif.

Figure 22. C-rich BDNF CD spectroscopy pH dependence. CD spectra of C rich BDNF
DNA over a range of pHs showing the destabilization of the i-motif at high pH.
To obtain information about the stability of the C-rich BDNF i-motif we performed UV
thermal-denaturation experiments at various pH values monitoring the absorbance changes at
288 nm, wavelength sensitive to the i-motif dissociation [154]. Figure 23 shows the thermal
destabilization of the i-motif structure from pH 4.25 up to pH 7.0. The hypochromic transition
observed at pH 4.25 begins to shift to the left, indicating i-motif destabilization by lower Tm, at
pH 5.25 and pH 5.75. Then at pH 6.25 the full hypochromic transition can no longer be seen
because at the start of the experiment, at 25 °C, the i-motif structure is already beginning to
dissociate.
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Finally, at pH 6.5 and pH 7.0 the absorbance increases which is indicative of single stranded
nucleic acids [155]. To determine if the i-motif structure is intramolecular or intermolecular the
Tm was measured at various DNA concentrations from 5-25 μM at pH 4.0. As seen in figure 24,
a hypochromic transition was observed, with a Tm of ~ 66 °C. The Tm does not depend on the

Figure 23. C-rich BDNF DNA UV/Vis. Shows the evolution of the thermodynamic profile of
the i-motif over a range of pH where the stability of the structure decreases as the pH is
increased over a range of pH from 4.75-7.0.
DNA concentration indicating that the i-motif is intramolecular (fig 24).
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Fig 24. UV/Vis determination of i-motif stability. (A) representative fitting of i-motif UV
thermal denaturation experiment. Hypochromic transition displays the melting temperature of
the structure. (B) shows no change in the melting temperature over the range of DNA
concentrations indicating an intramolecular formation.
Chapter 4.6 BDNF DNA duplex is in equilibrium with GQ and i-motif structures. When
isolated, G rich BDNF DNA folds into a GQ structure, whereas C rich BDNF DNA folds into an
i-motif structure. However, since the G-rich and C-rich BDNF DNA sequences are perfectly
complementary to one another, when in the presence of one another they could form a duplex
structure that will be in competition with the GQ and i-motif structures. 1H NMR spectroscopy
was used to monitor the resonances in the imino proton region to monitor the competition
between the duplex, GQ, and i-motif structures. The sample was prepared at room temperature at
pH 6.5 in 10 mM cacodylic acid buffer.
Equimolar concentrations of the G-rich BDNF and the C-rich BDNF DNAs were mixed
in 10 mM cacodylic acid buffer pH 6.5, at room temperature, monitoring the changes in the
imino proton resonance region from 10-16 ppm. As seen in Figure 25 after 3 hours incubation
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time a new set of imino proton resonances appear in the 12-14 ppm range, corresponding to the
formation of

Figure 25. Time dependent 1H NMR of C-Rich + G-rich BDNF DNA. (A) The equilibrium
of the i-motif and GQ with the duplex structure was monitored over time. The top two spectra
are references to each structure’s resonances individually, and then the spectra below were
acquired at the different time points indicated after the G rich and C rich BDNF DNAs are
mixed in a 1:1 ratio. (B) The G-rich mutation and C-rich mutation sequences were mixed in a
1:1 ratio and their spectra were acquired after 3h, after which the sample was boiled and slow
annealed to promote duplex formation.
Watson-Crick base pairs in the BDNF DNA duplex. Concomitantly, the resonances for the GQ
and i-motif decrease in intensity. While the duplex conformation seems to be favored,
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resonances for the GQ and i-motif are present even after 48 h. After 128 hours the signals for the
GQ and i-motif are greatly diminished, but nonetheless still present, and even upon boiling and
slow annealing the sample to promote the duplex formation, resonances for the GQ and i-motif
are
still present.
Note that the GQ resonances apparently have lower intensity than the i-motif ones,
however, the signals from all the C+-C base are overlapped resulting in a larger signal, whereas
those from the GQ are well separated and thus much lower in signal intensity. This result
suggests that, while the duplex is the preferred structure, the GQ, i-motif, and duplex structures
can co-exist in equilibrium even in the absence of protein factors that might shift this equilibrium
by binding to each of these structures. Figure 25B are the results for the mixing of the G-rich
BDNF DNA & C-rich BDNF DNA.
Chapter 4.7 BDNF GQ/i-motif structure affects transcript length. The data presented here
shows the in vitro formation of the GQ and i-motif structures in the BDNF DNA. Our
collaborator at Emory School of Medicine, Dr. Yue Feng, conducted CHiP pull down assays on
brain cells and luciferase assays in vivo to ascertain if the noncanonical structures are influencing
the choice of the APA site within BDNF and hence the BDNF mRNA transcript length.
CHiP assays were conducted with an antibody specific for RNA polymerase II (RNAP
II). This pulled down all the RNAP II within the targeted cells. Since RNAP II is the primary
RNA polymerase accountable to produce RNA transcripts in cell it will be bound to a large
number of DNA fragments. However, to analyze the specific fragments of BDNF DNA that the
RNAP II was bound to qPCR primers were designed for sections of the BDNF 3-UTR before the
GQ (red arrows in figure 26A), spanning the GQ (yellow arrows in figure 26A), and after the GQ
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(light blue arrows in figure 26A). Additionally, a primer was made for the BDNF open reading
frame (ORF) as a control (purple arrows in figure 26A). These experiments were performed in
the hippocampus (figure 26B) and in primary cortical neurons (figure 26D) and in both cases,
there was a significant buildup of the RNAP II at the reporter site up-stream of the GQ structure
(red columns). Additionally, using qRT-PCR the amount of BDNF long and short mRNA

Figure 26. BDNF GQ causes stalling of RNAP II. (A) schematic of the BDNF mRNA
illustrating the location of GQ/i-motif and the two polyadenylation sites. (B & D) Pol II ChIP
in the tissue/cell indicated. The regions of qPCR primers are color coded and indicated on the
upper right corner. (C & E) qRT-PCR quantification of endogenous BDNF long and short
mRNA extracted from gel
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transcripts were quantified from gel extracts both in the hippocampus (figure 26C) and in the
primary cortical neurons (figure 26E). Obviously, there is a larger amount of the short transcript,
consistent with the hypothesis that when the RNAP II pol is being paused before the GQ, the
proximal APA site near the GQ structure is used more often, leading to the early termination of
transcription and the production of more of the BDNF mRNA short transcript.
Figure 27A shows the model system for the luciferase reporter gene fused with the
BDNF 3’-UTR used to compare the levels of long and short BDNF transcripts made between the
WT BDNF and the BDNF Mutant (which cannot form a GQ structure) previously characterized
in vitro. Figure 27B shows the levels of long and short BDNF mRNAs from cells transfected
with the WT and Mut plasmids extracted from RNA size-fractionated agarose gel. The WT
clearly has a lighter band for the BDNF mRNA long transcript relative to the short transcript.
However, for the mutants (Mut) the band for the long transcript significantly darkens,
indicating that more of the long transcript is made. Figure 27C shows the relative percent change
in the ratio of BDNF long:short transcript made based on the quantification of the bands shown
in figure 27B. This was done by normalizing the ratio of BDNF long:short in the WT to 100%
and then comparing the ratio of long:short in the case of the mutation. An approximately
threefold increase in production of long transcript can be observed in the mutation, consistent
with the idea that when the GQ structure is disrupted, the RNAP II is no longer paused and the
proximal APA site is not preferred anymore. Figure 27D shows the luciferase activity in the WT
and Mut, and a significant decrease in the luciferase activity can be seen in the Mut, which is
expected since the long transcript BDNF is not as well translated as the short one. This result is
consistent with the presence of a higher ratio of the long to short transcript in the Mut. The
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renilla Luciferase co-transfected was used to normalize the fire fly luciferase activity in detected
by the dual luciferase assay to normalize transfection efficiency of each reporter.

Figure 27. BDNF GQ regulates transcript length in a luciferase reporter. (A) schematic
presentation of the fire fly luciferase reporter fused with the BDNF 3’-UTR. (B) Detection of
the long and short BDNF reporter mRNAs from cells transfected with the WT and Mut
plasmids using RNA size-fractionated from agarose gel by RT-PCR using luciferase coding
region primers. (C) Relative abundance of the long and short BDNF reporter mRNAs derived
from WT and Mut plasmids in transfected cells. (D) Consistent with the previous study that
demonstrates BDNF long 3’UTR suppresses reported translation, and thus we see a reduction
in activity.
These results provide strong evidence that the GQ formation proximal to poly(A) sites
has a direct effect on polyadenylation. There is precedence for this in the literature [129-131],
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however none of these studies investigated or proposed the mechanism behind why or how the
GQ is providing this regulation. This is the first study showing that a GQ structure formed in
DNA near an APA site pauses the RNAP II and leads to the usage of that APA site more often,
leading to an increase in a short transcript. Figure 28 shows a model for how RNA polymerase
could be interacting with the GQ/i-motif structures in the DNA during transcription. Figure 28A
shows the normal transcription process with RNA polymerase making the RNA from the
template strand unhindered and transcribing both poly(A) signals (PAS 1 & 2). In Figure 28B the
GQ and i-motif are present and hinder the progress of the RNA polymerase, pausing it. This
gives the polyadenylation machinery time to assemble on the proximal poly(A) site and thus lead
to an increased production of the short 3’-UTR BDNF mRNA.

Figure 28. Model depicting transcription with GQ/i-motif. A.) The RNA polymerase
transcribes the RNA uninterrupted and adds both poly(A) signals. B.) The RNA polymerase is
slowed down by the GQ/i-motif sites and poly(A) site 1 is favored.
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RNAP II is a highly regulated component of gene expression. The pausing of RNAP II
has been linked to the accumulation of transcriptionally engaged transcripts prior to gene
induction, leading one to believe that RNAP II pausing is a common mechanism for gene
regulation [156].
GQ has already been identified as a localization signal for specific targeting [157];
studies have already observed this with FMRP [158] and thus it’s not out of the question to
assume GQs can be targeted by other protein factors. In fact, Ewing’s sarcoma (EWS) and fused
in sarcoma (FUS) proteins also contain an RGG box domain that has been shown to specifically
target GQ [159, 160].
The GQ and the proteins that bind such structure could be acting as regulators of
alternative polyadenylation in certain genes. Since GQ structures are so stable the formation of
the GQ could pause the RNAP II and allow for the assembly of the polyadenylation machinery
on the pre-mRNA. A previous study already showed GQ formation was essential in the
processing of p53 pre-mRNA during DNA damage [161]. For LRP5 3′-UTR, the GQ structure
was the key element for efficient transcription. The GQ directly determined the levels of mRNA
produced acting as an upstream control for the levels of protein produced [129].
Additionally, we characterized the i-motif forming sequence in the BDNF DNA opposite
of the GQ. Recent studies have shown that the i-motif formation in vivo is dependent on cellcycle and pH, but there have been reports of it forming at neutral pH [162]. I-motif formation has
been observed in vivo with the help of a specific antibody, iMab, showing that the i-motif does
exist in the cell and plays an important role in regulation of promoter and telomere regions [163].
Since any system where a GQ is forming in the DNA will have a C-rich complement studies
have gone back to investigate if the i-motif is playing role in any of these systems. It was found
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that i-motif formation in the 5’-UTR of the KRAS gene was having an effect on gene expression
[164]. A similar study observed i-motif formation in the MYC promoter region and this structure
is now being targeted by drugs, leading to a delay in tumor growth [165]. These new reports shed
light on to the legitimacy of the i-motif as a target for therapeutics and its role in gene regulation.
Another study delved deep into the folding of i-motif and how to use pH as a switch which
would help design more intricate therapeutic models [166] to the point where cancer therapies
are being designed with i-motif in mind to create triple combinatorial anti-tumor therapy [167].
Not only is the amount of mRNA transcribed being affected by the GQ formation in the
DNA, but the length of the transcript is also being modulated. This is significant because 3’-UTR
shortening can lead to lose of regulatory motifs, such miRNA and RBP binding sites, which will
affect the translation of the transcript [168]. If these regulatory motifs are lost in the shortened
transcript it may mean that the translation is shut off because an important localization/activation
signal is lost; the loss of regulatory motifs could also mean that the transcript is translated
without having an off-switch leading to over expression [169]. Either way, the translation will be
disrupted from its normal state and this can lead to disease states.
Chapter 4.8 BDNF mRNA GQ and FMRP. We previously showed the formation of a GQ in
the 3’-UTR of the BDNF DNA, based on that we postulated that the GQ will also form in the
RNA. The mRNA transcript can also be post-transcriptionally processed in the cytoplasm after
being released from the nucleus and the RNA GQ could be acting in a similar way as the DNA
GQ. Thus, we inquired if the RNA GQ in the BDNF 3’-UTR could be having a regulatory effect.
Since BDNF is another neuronal target of FMRP we chose to investigate if FMRP is specifically
targeting this GQ, by binding to such structures, FMRP could affect the length of the transcript.
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The BDNF mRNA GQ was characterized by Snezana Stefanovic (data not shown), her results
indicating that BDNF mRNA forms a parallel, intramolecular GQ structure.
To determine if FMRP is specifically targeting the BDNF GQ in the mRNA, first we
utilized gel electrophoresis to observe whether the FMRP RGG box and BDNF mRNA were
binding. Figure 29 shows the formation of an upper band (indicative of the complex formation)
even at a 1:1 ratio. At a ratio of 1:2 it appears that BDNF mRNA is fully bound, figure 29, lane
3.
Steady-state fluorescence spectroscopy was next used to determine a quantitative
dissociation constant for the affinity between FMRP and the BDNF mRNA. Using a 2AP
substitution, position shown in table 3, we were able to monitor the change in fluorescence as
full-length FMRP was titrated in 50 nM increments. The binding curves were done in triplicate
and figure 29B shows that the affinity for the interaction is strong, with a Kd of 53.2 ± 11.6 nM.
Thus, it is possible that FMRP is binding the GQ in the BDNF mRNA and acting as a beacon to
potentially recruit the polyadenylation machinery. This could be another level that the BDNF GQ
could be exerting regulation, acting as a failsafe in the event that BDNF DNA GQ was unable to
regulate.
Chapter 4.9 Conclusions. The GQ discovered in the 3’-UTR of the BDNF gene in this study is
significant to understanding the mechanism behind how the body modulates the transcript length
of BDNF. Patients with decreased levels of the long 3’-UTR BDNF transcript have impaired
mental functioning, thus uncovering how the ratio of short: long 3’-UTR is regulated is
important to understanding this system. As we have shown, the GQ formation proximal to
poly(A) site 1 is leading to an increase in the short 3’-UTR BDNF transcript. Thus, protein
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factors that bind and stabilize/destabilize such structures could affect the choice of APA and
regulate the ratio of short: long BDNF transcripts.
BDNF is an interesting system that merits discussion because it acts as a model for a new
potential mechanism of regulating poly(A) site choice and transcript shortening. Whether it is
working on the DNA level, or the RNA level (or both) the BDNF GQ system is another unique
model that could help elucidate how similar systems are functioning. Transcript shortening can
affect translation and lead to impaired functioning. The GQ structure is the key to this
mechanism, in BDNF and other likewise sequences, and understanding the formation and
interactions it has within the system is pivotal to the development of a treatment plan or
therapeutic to help reestablish homeostasis in affected patients.

Figure 29. BDNF mRNA binding FMRP. (A) BDNF mRNA binding FMRP RGG box in
gel. (B) Representative binding curve for BDNF mRNA and FMRP.
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Chapter 5: GQ formation in pre-miRNA-149 disrupts mature miRNA production
Chapter 5.1 GQ and miRNA. The biogenesis of mature miRNA, named the miRNA pathway
(figure 30) and is a complex process that involves several consecutive processing and cleavage
steps ultimately leading to the repression of protein synthesis for specific mRNA targets [170,
171]. The first stage is the transcription of the miRNA gene to the primary-miRNA (primiRNA). Once the pri-miRNA is expressed in the nucleus it is processed by DROSHA in
complex with DGCR8 to form the premature-miRNA (pre-miRNA) [172], which is then
exported to the cytoplasm by exportin 5 (EXP5) for further processing [173]. At this stage the
long-extended hairpin structure of the pre-miRNA is targeted by Dicer and TRBP for further
processing [174]. Dicer cleaves the pre-miRNA resulting in a 22-24 nt miRNA:miRNA* duplex.
One of the strands, named the passenger strand and denoted by miRNA*, is degraded, leaving
the single stranded mature miRNA [175]. Dicer then helps recruit Ago2 to find the mature
miRNA and incorporate it in RISC (RNA-induced silencing complex) to form the RISC:miRNA
complex [176, 177]. This complex then moves to the miRNA-sequence specific target on the
mRNA and leads to the repression of that transcript.
Focusing on the pre-miRNA, experiments have shown that knockdowns of EXP5 lead to
a reduction in mature miRNA levels, without a buildup of pre-miRNA in the nucleus [178],
suggesting that EXP5 does more than just export the pre-miRNA to the cytoplasm, it also likely
protects it from nuclease activity. Once the pre-miRNA is in the cytoplasm it is processed by
Dicer to produce the mature miRNA. Dicer requires a specific sequence recognition, the 2-nt 3’
overhang, to bind and process, therefore any change in the pre-miRNA secondary structure may
lead to a disruption of the Dicer cleavage and mature miRNA production [179].
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Figure 30. The miRNA pathway. Displays the steps of miRNA production from DNA to
mature miRNA. The bottom left shows a schematic of the central dogma.
It is obvious that the miRNA pathway is a complex mechanism that has many steps that
are highly regulated. There have already been reports of various proteins that regulate primiRNA and pre-miRNA indirectly by interacting with protein factors, such as Drosha and Dicer,
or by binding directly to the miRNA precursors [180 and references therein].
Chapter 5.2 GQ and the miRNA pathway. One recent paper discusses the effect GQ formation
in the pre-miRNA has on the maturation of microRNA [33]. Preliminary studies show that this
alternative structure has a dramatic effect on the maturation of the miRNA, as the GQ disrupts
the normal structural recognition motif for Dicer. A bioinformatics search was done by the same
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group and they found that, at minimum, 13% of all pre-miRNA have the potential to form GQ
structure [33]. Thus, there is a contingent of miRNA that can be specifically regulated through
the GQ targeting mechanism. For these miRNAs drugs can be developed to stabilize/destabilize
the GQ structure and manipulate the expression of mature miRNA levels elucidating a new
regulatory control mechanism. An even more recent paper found results that further strengthen
this theory by investigating GQ formation in the pri-miRNA and how manipulation of the GQ
structure directly affects levels of mature miRNA produced [181].
Since secondary structure is so important to the targeting and processing of pre-miRNA
it is no surprise that genetic polymorphisms have been associated with a decrease in processing
efficiency; which will lead to dysregulation of miRNA targets. miR-149 is one such miRNA,
with genetic polymorphisms leading to an increased risk for miR-149 related cancers [182, 183].
A recent study showed a genetic variation in the pre-miR-149, an A to G single nucleotide
polymorphism (SNP), that leads to a significant decrease in the amount of mature miR-149
produced [184]. Upon investigation of pre-miRNA-149 sequence we observed potential GQ
formation that could be regulating the production of mature miR-149. Additionally, we predict
the pre-miR-149 SNP (A to G) is forming a secondary GQ that is directly leading to the
reduction in mature miR-149 produced (Fig 31).
At the time of writing this, a paper published this year has investigated specifically miR149 and it’s function within cancer. They show that miR-149 is predicted to target oncogene and
tumor suppressor within cancers. miR-149 is involved in the ERBB-pathway, insulin signaling
and MAPK signaling, which are all necessary for tumor growth [185]. Studies have shown that
miR-149 has anti-cancer properties, in which miR-149 has participated in drug sensitivity and
cancer resistance [186, 187].
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Figure 31. pre-miRNA-149 structure. Schematic of the pre-miR-149 showing the longextended hairpin and the locations of the predicted GQ structures.
Still, the mechanism behind how and why miR-149, and its polymorphisms, are affecting these
systems is unknown and in this study, we propose that the GQ formation in the pre-miR-149 is
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the primary regulatory factor in determining the production of mature miR-149, and hence its
effectiveness in suppressing tumor growth. We predict that the GQ acts like an on/off switch for
the production of mature miR-149; we know that a lower expression of mature miR-149 leads to
disease states [188]. Clearly, miR-149 is an important miRNA for therapeutic development and
potential biomarker for numerous cancers.
Chapter 5.3.1 GQ formation in pre-miRNA-149 WT. We used a GQ prediction software,
QGRS mapper [60], to analyze the pre-miRNA-149 sequence and found a GQ forming sequence
with a high G-score, indicating high stability, (GQ1). Additionally, when we analyzed the premiRNA-149 SNP sequence using QGRS mapper we found another GQ forming site centered
around the SNP with a low G-score, indicating lower stability, (GQ2).

Table 4. Sequences used in the pre-miR-149 project.

Chapter 5.3.2 Biophysical characterization of pre-miRNA-149 GQ1. First, we sought to
prove the formation of the GQ1 sequence within the pre-miR-149. The oligonucleotide matching
the predicted GQ1 forming sequence was ordered and chemically synthesized by Dharmacon,
Inc. 1D 1H NMR spectroscopy was used to observe the secondary structure in the pre-miR-149
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GQ1 sequence (Fig 32A) [189]. The imino proton resonances for GQ formation were observed
between 10-12 ppm, whereas the resonances associated with canonical Watson-Crick base pairs
are in the 12-14.5 ppm range [190, 191]. Increasing concentrations of K+ ions were titrated into
the sample to promote GQ formation. We observed a strong signal in the 10–12 ppm region for
the pre-miRNA-149 GQ1 RNA, even in the absence of K+, indicating GQ formation (Figure
32A, bottom spectrum). Upon titration of 10 mM K+ the resonances become sharper indicating
stabilization of specific GQ confirmations, opposed to the broad spectra at 0 mM KCl. This trend
follows up to 150 mM KCl annealed where the bands begin to broaden again, indicating that
annealing at this concentration of KCl allows for multiple stable conformations.

Fig 32. Biophysical characterization of pre-miRNA-149 GQ1. 1H NMR spectra of 200 µM
pre-miRNA-149 GQ1 at increasing KCl concentrations in 10 mM cacodylic acid buffer, pH
6.5, at 25 °C (A). CD spectra of pre-miRNA-149 GQ1 at 10 µM RNA sample with increasing
KCl concentrations in 10 mM cacodylic acid buffer (B). UV/Vis spectroscopy thermal
denaturation data for pre-miRNA-149 GQ1 over a range of concentration, 5-50 µM, at
constant KCl concentration, 10 mM (C). pre-miRNA-149 GQ1 melting temperatures at 10
mM KCl as a function of RNA concentration (D).
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Circular dichroism (CD) spectroscopy was utilized to examine the fold of the GQ [67,
68]. GQ structures can take on different folding arrangements that each have a unique CD
signature [69]. We observed a positive band at around 265 nm and a negative band around 240
nm for the pre-miRNA-149 GQ1 sequence indicating that it forms a GQ with parallel topology
(Fig 32B). From 0 mM KCl to 10 mM KCl there is a significant increase in the signal, but
increasing the K+ concentration beyond 10 mM KCl does not result in additional spectral
changes, consistent with the NMR data.
UV/Thermal denaturation experiments were done to characterize the thermodynamic
profile of the pre-miR-149 GQ1. Determination for whether an intramolecular and
intermolecular GQ is formed can be made using this technique by keeping a constant KCl
concentration (10 mM KCl) and varying the RNA concentration over a range, 5-50 µM, while
slowly ramping the temperature from 25-95 °C and monitoring the change in absorbance at 295
nm, wavelength sensitive to GQ denaturation [20]. For intramolecular structures the melting
temperature is independent of the RNA concentration (see Chapter 7 Materials and Methods,
equation 1 & 2). For the pre-miRNA-149 GQ1 there is a hypochromic transition observed at ~81
°C for all RNA concentrations indicating the formation of an intramolecular GQ (Fig 32C/D).
Chapter 5.3.3 Biophysical characterization of Pre-miRNA-149 WT. After having shown that
the pre-miR-149 GQ1 can form a GQ, we next investigated whether this structure could still
form in the context of the full-length WT. We produced the pre-miRNA-149 WT sequence by in
vitro transcription reaction using a synthetic DNA template (TriLink BioTechnologies, Inc). We
analyzed the entire 90 nt pre-miRNA-149 sequence to determine if GQ1 structure could compete
with the canonical long-extended hairpin for pre-miRNA (Figure 31). 1D 1H NMR was used to
investigate the structure of the pre-miRNA-149 WT (Fig 30A). We can see that there are no
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resonances in the GQ region from 10-12 ppm, even up to 150 mM KCl. However, there are
numerous resonances between 12-14 ppm, indicative of Watson-Crick base pairing and can be
attributed to the formation of the long-extended hairpin structure. Only once the sample has been
annealed in 150 mM KCl do the resonances for the GQ appear with an equivalent decrease in the
Watson-Crick resonances (Fig 33A). Next, we added 1 mM MgCl2, known to stabilize the
hairpin structure and not the GQ, to observe the equilibrium between GQ and hairpin over time
(Fig 33B) [192]. Over time, the hairpin structure is favored, however the resonances for the GQ
never completely disappear.

Fig 33. Biophysical characterization of pre-miRNA-149 WT. 1H NMR spectra of 150 µM
pre-miRNA-149 WT at increasing KCl concentrations in 10 mM cacodylic acid buffer, pH 6.5
(A). Time dependent 1H NMR spectra of pre-miRNA-149 WT after adding 1 mM MgCl2 to
observe the equilibrium between GQ and long extended hairpin structures (B). UV thermal
denaturation data for pre-miRNA-149 WT (C). Alignment of the UV thermal denaturation
profiles between pre-miRNA-149 WT and pre-miRNA-149 GQ1 showing that they both
contain the same hypochromic transition for GQ1 (D).
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It is important to note that in vitro there are no additional factors that could be helping
stabilize/destabilize GQ formation that may be present in vivo. This leads us to the conclusion
that there is an equilibrium between the structures that can be balanced depending on external
stimuli and other cellular factors.
The 1H NMR data showed that a GQ structure was forming within the WT. We
performed the thermal denaturation experiments on the pre-miRNA-149 WT sequence and
observed a hyperchromic transition with a Tm at ~60 °C which we attribute to the hairpin
denaturation (Fig 33C) [193], and also a hypochromic transition with a Tm at ~80 °C which we
attribute to the previously characterized GQ1 quadruplex (Fig 33D). Thus, our data points to the
formation of the GQ1 structure in pre-miRNA-149 WT, that co-exists in equilibrium with a longextended hairpin structure.
Chapter 5.4.1 Formation of pre-miRNA-149 GQ2 within the SNP sequence. As mentioned
previously, when analyzing the pre-miRNA-149 SNP sequence the formation of an additional
GQ is predicted centered around the SNP (A to G). This quadruplex, named GQ2, only has the
potential to form with two G-quartet planes (Fig 31). Thus, we set out to characterize the 12-mer
pre-miRNA-149 GQ2 sequence.
Chapter 5.4.2 Biophysical characterization of pre-miRNA-149 GQ2. 1D 1H NMR was
conducted as previously described to monitor the imino proton resonances for the formation of
GQ with respect to K+ titrations. At 0 mM KCl there are obviously resonances indicative of GQ
formation (Fig 34A). There is also a small resonance in the Watson-Crick region at 13.2 ppm. As
KCl is added to the sample the resonances in the GQ region begin to increase in intensity and the
Watson-Crick resonance begins to decrease in intensity. At 150 mM KCl annealed the
resonances for the sample become very sharp indicating the stabilization of the GQ2 structure.
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CD spectroscopy was done to investigate the fold of pre-miRNA-149 GQ2. The spectra
shows a positive band at 265 nm and a negative band at 240 nm indicative of a parallel GQ. The
signal however is relatively low intensity and does not change from 0 mM KCl up to 150 mM
KCl (Fig 34B).

Fig 34. Biophysical characterization of pre-miRNA-149 GQ2. 1H NMR spectra of 200 µM
pre-miRNA-149 GQ2 at increasing KCl concentrations in 10 mM cacodylic acid buffer, pH
6.5, at 25 °C (A). CD spectra of pre-miRNA-149 GQ2 at 10 µM RNA sample with increasing
KCl concentrations in 10 mM cacodylic acid buffer, pH 6.5 (B). UV/Vis spectroscopy thermal
denaturation data for pre-miRNA-149 GQ2 over a range of concentration, 5-50 µM, at
constant KCl concentration, 150 mM (C). pre-miRNA-149 GQ2 melting temperatures at 150
mM KCl as a function of RNA concentration, 5-50 µM (D).
Next UV/Vis spectroscopy was used to perform thermal denaturation experiments to
characterize the thermodynamic profile of the pre-miRNA-149 GQ2 sequence. There is not a
clearly defined hypochromic transition at ~55 °C (Fig 34C). Previous studies have shown that
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GQs with less planes are less stable so it makes sense that a two plane GQ is less stable than a
three plane GQ [194]. The profile was characterized at a constant KCl concentration, 150 Mm,
over a range of RNA concentrations, 5-50 µM however being unable to fit the transition for a
quantitative melting temperature, we turned to gel electrophoresis as a supplemental technique to
probe the structural formation. Figure 34D shows the GQ2 structure in a 20% native
polyacrylamide gel at various concentrations, 5, 10, 20, 50 µM respectively, in 150 mM KCl. It
can be seen that no additional bands form in the band (which would indicate intermolecular
formation). This combined with the UV/Vis data indicate an intramolecular formation for the
GQ2 structure.
Chapter 5.4.3 Biophysical characterization of the full-length pre-miRNA-149 SNP. Having
characterized GQ2 by itself, the next step was to look at its formation in the context of the fulllength sequence. Pre-miRNA-149 SNP sequence was produced via in vitro transcription reaction
using a synthetic DNA template (TriLink BioTechnologies, Inc). 1D 1H NMR was done to
investigate the structure of the SNP. In contrast to the WT, which had no resonances in the GQ
region even up to 150 mM KCl, the SNP has resonances present in the GQ region even at 0 mM
KCl (Fig 35A); however, because they are sharper than the GQ resonances and also their
intensity does not change upon the addition of KCl we resign these resonances centered around
10.5 ppm may be due to G-U base pairs. Once reaching 150 mM KCl and annealing the sample a
significant decrease in the intensity of Watson-Crick resonances is observed with a concomitant
increase in the intensity of the GQ resonances, which are centrally shifted towards 11 ppm. The
resonances between 10-12 ppm appear different between pre-miR-149 WT and pre-miR-149
SNP within the GQ region (compare figure 33A and 35A). The only difference between the two
sequences is the SNP (A to G), so it is reasonable to assume if the resonances around 10.5 ppm
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were G-U base pairs they would also be present in the WT, which they are not. This indicates
that there is an additional structure contributing to the resonances around 10.5 ppm in the SNP,
which we believe is GQ2 forming due to the SNP (A to G).
1 mM MgCl2 was then added to the sample and the resonances were monitored over time
(Figure 35B). Overtime the intensity of the GQ resonances decrease with a concomitant increase
in the intensity of the Watson-Crick resonances. However, this differs from the time dependent
pre-miR-149 WT NMR data in that the resonances in the GQ region for the SNP do not decrease
nearly as much as the GQ resonances did in the WT (compare figure 32B & 34B). We attribute
this to the formation of the secondary quadruplex, GQ2, helping stabilize the formation of GQ1
and shift the overall equilibrium between the structures to the GQ state.

Fig 35. Biophysical characterization of pre-miRNA-149 SNP. 1H NMR spectra of 150 µM
pre-miRNA-149 SNP at increasing KCl concentrations in 10 mM cacodylic acid buffer (A).
Time dependent 1H NMR spectra of pre-miRNA-149 SNP after adding 1 mM MgCl2 to
observe the equilibrium between GQ resonances and Watson-Crick resonances (B). UV
thermal denaturation data for pre-miRNA-149 SNP (C). Alignment of the UV thermal
denaturation profiles between pre-miRNA-149 SNP and pre-miRNA-149 GQ2 showing that
they both contain the same hypochromic transition for GQ2 (D).
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Additionally, UV/Vis thermal denaturing experiments were conducted on pre-miR-149
SNP to determine if another GQ hypochromic transition could be seen, to further prove that the
SNP creates another GQ within the pre-miR-149 sequence. As can be seen in UV profile (figure
33C) an additional hypochromic transition can be seen starting around 40 °C however the
complete transition cannot be seen. Comparing the new transition seen in the SNP to the GQ2
profile (figure 33D) we are able to line up the transitions and infer the formation of GQ2 in the
SNP. Note the spectra do not line up perfectly, we attribute this to the overlap in transitions in
the SNP spectra because we will have the end of GQ2 and the beginning of the hyperchromic
hairpin transition overlapping, which we can see continues on in the GQ2 UV independently.
The 1H NMR resonances for the SNP are different from the WT and the only difference
between the sequences is a single nucleotide, the formation of the second GQ explains the
significant change in spectra. We believe that all the data together points to the existence of GQ2
in the SNP. In summary, we show that the SNP (A to G) in the pre-miRNA-149 is leading to the
formation of a secondary GQ.
Chapter 5.5 GQ formation in pre-miRNA-149 SNP sequence disrupts dicer processing in
vitro. The formation of GQ in the pre-miRNA-149 sequence is important to the maturation of
miR-149. Previous studies have shown that the pre-miRNA-149 SNP (A to G) produces less
mature miR-149 [19]. We predict that the formation of the secondary GQ2 due to the SNP (A to
G) is the cause. However, to investigate the pre-miR-149 SNP effect on miR-149 maturation we
utilized a fluorescent molecular beacon screening assay (outlined in materials in methods). This
experiment utilizes a molecular beacon, which is a synthesized sequence that will form large
loop. In this loop is a perfectly complementary sequence to the target molecule, mature miR-149
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in this case. At the ends of the molecular beacon are a 6-FAM fluorophore (5’) and a BHQ-1
quencher (3’). When they are folded in their natural state there will be little to no fluorescence
because the quencher will be nearby. When the loop recognizes its target and binds however, the
hairpin will unfold separating the 5’ and 3’ ends thus separating the fluorophore from the
quencher and resulting in an increase in fluorescence.
A molecular beacon was chemically synthesized and ordered from Sigma. Figure 36A
shows its sequence and how it is perfectly complementary to the mature miR-149. In a control
experiment we first incubated the molecular beacon with the mature miR-149 which was
chemically synthesized, and as seen in figure 36B, as expected, the fluorescence increases
significantly due to the opening of the beacon by the mature miR-149 and the formation of the
miR-149-beacon duplex. Next the beacon was used to monitor the production of the mature miR149 by Dicer through the processing of the pre-miRNA-149. In our experimental setup pre-miR149 was first incubated with Dicer for two hours at 37 C, after which proteinase K was added to
the system to digest Dicer and stop the processing of the pre-miR-149. To monitor how much of
the mature miR-149 was produced we then incubated the results of the reaction described above
with the molecular beacon that is perfectly complementary to the mature miR-149, monitoring
the fluorescence changes of the beacon over 16 hours (figure 36 C and D). In one set of
experiments pre-miR-149 was annealed in the presence of KCl to stabilize the formation of GQ
structures (figure 35C), whereas in the second no KCl was added to the sample, only MgCl2 to
stabilize the long-extended hairpin structure (figure 36D). It should also be noted that the Dicer
activity is inhibited in the presence of KCl, so we cannot directly compare the results in KCl
versus MgCl2, but only compare the pre-miR-149 processing by Dicer for the WT versus the
SNP in each set of conditions.
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In the presence of KCl there is a slight difference between the pre-miR-149 WT and SNP,
with the WT having a larger overall increase in the fluorescence. This result makes sense,
considering the WT only has one GQ compared to the SNP which will has two GQs and
therefore the potential to disrupt the Dicer processing more. Figure 35D has the pre-miRNA-149
samples prepared in the absence of KCl which should not facilitate the GQ formation. However,
from our previous characterization, the pre-miR-149 SNP sequence has the potential to form the
GQ structure even in the absence of KCl, whereas the WT sequence cannot form the GQ unless
KCl is present and the sample is annealed (compare figure 33A and figure 35A). Figure 35D
shows that in the absence of KCl (where the SNP has a GQ and the WT does not) there is a
significant increase in the fluorescence for the WT sequence. Again, this result suggests that
since the WT is in the correct long extended hairpin structure Dicer will recognize and process it
resulting in more mature miR-149 which will bind to the molecular beacon, as compared with
the pre-miR-149 SNP sequence which will have a population forming the GQ structure and
consequently disrupting Dicer processing.
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Figure 36. Molecular Beacon Dicer Assay. (A) RNA structure representation of the
molecular beacon and its perfect complementarity to mature miR-149. (B) control showing the
beacon works with mature miR-149. (C) Dicer assay where the pre-miRNA-149 WT and SNP
samples were prepared in the presence of KCl. (D) Dicer assay where the pre-miRNA-149 WT
and SNP samples were prepared in the absence of KCl.

Chapter 5.6 GQ formation in pre-miR-149 regulates miRNA maturation. Formation of GQ
structure in pre-miRNA has already been reported previously [195]. Thus, there is precedent for
GQ regulating mature miRNA levels [33]. We have specifically investigated the pre-miRNA-149
system and offered a model as to why a SNP (A to G) has been observed to produce lower levels
of mature miRNA-149. Upon analyzing the sequence GQ1 was predicted to be and as shown by
the NMR data this GQ is not present unless the sample was annealed in the presence of 150 mM
KCl. This leads us to believe that GQ1, although a stabile GQ on its own, is not the primary
regulator. The secondary GQ, GQ2, is centered around the SNP (A to G) which is found at the 3’
end of the hairpin. Although this is a two plane GQ, its positioning in the structure gives it
unique leverage. Due to it being at the end of the hairpin we believe it is acting as a zipper to
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help open up the hairpin enough for GQ1 to form. The NMR data shows that even at 0 mM KCl
in the SNP sequence GQ imino proton resonances are present. Thus, it is possible that the two
GQ in the SNP work in concert to shut off the production of miRNA-149. Pre-miRNA-149 GQ2
is able to form initially and open up the hairpin and allow the more stable GQ1 to then form and
together they effectively reduce the Dicer processing significantly (Fig 35). Although the two
GQs found within pre-miRNA-149 may be unique, the theory is general enough and applicable
to the field overall. Earlier studies speculate that 13% of all pre-miRNA sequences have the
potential to form GQ. However, by opening up the parameters to account for smaller, potentially
less stable GQs (such as GQ2), up to 25% of all miRNAs could potentially be affected by this
mechanism [196].
This is an exciting angle to investigate in the field currently as miRNAs are known to be
highly involved in cancer development. Thus, understanding the mechanism behind miRNA
regulation allows for another avenue of therapeutic development targeting cancer related
miRNAs.
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Chapter 6. Summary and conclusions.
Chapter 6.1 NR2B GQ structure in the 3’ UTR is specifically targeted by FMRP. The data
presented here shows that a GQ structure is forming in the 3’ UTR of NR2B mRNA and this GQ
is specifically targeted by FMRP. Cell lysate pull downs from E17 mouse brains show that the
NR2B GQ by itself is sufficient to pull down endogenous FMRP. Steady-state fluorescence
experiments were performed to ascertain a quantitative affinity for the interactions between the
NR2B GQ and FMRP. The dissociation constants, Kd, of 370 ± 29 nM for the complex formed
by NR2B mRNA with FMRP and Kd of 201 ± 25 nM for the complex formed with FMRP
S500D show that the FMRP isomimic binds with slightly higher affinity to NR2B mRNA than
the unphosphorylated FMRP. These results show that FMRP is specifically targeting the GQ
structure and binding with a nM affinity to regulate the production of the NR2B gene product,
adding NR2B to a growing list of genes that are targeted and regulated by FMRP through a GQ
binding mechanism.
Chapter 6.2 PSD-95-Q1Q2 translation is modulated by FMRP phosphorylation. Previous
studies have reported that FMRP inhibits PSD-95 translation. They show that the PSD-95 mRNA
translation is inhibited only if FMRP is phosphorylated, and that the FMRP dephosphorylation
reactivates PSD-95 translation. Our data presents a mechanism how depending on its
phosphorylation status, FMRP works in conjunction with the microRNA miR-125a to regulate
the translation of PSFD-95 mRNA. Our data shows that FMRP S500D (phosphomimic of
FMRP) has a higher affinity for the PSD-95 GQ system forming in the PSD-95 Q1Q2 sequence.
Moreover, we discovered that FMRP S500D has a high affinity for miRNA-125a, whereas,
interestingly, the unphosphorylated FMRP appears to have no affinity for the miR-125a. We
propose that the phosphorylation on the protein reorients the KH domains for binding to the
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miRNA. Mutation studies on the proposed binding site in miRNA-125a, UAAC, show that the
binding is significantly reduced when this motif is disrupted. This coupled with the studies that
show FMRP phosphorylation is required for interactions with Ago2, an important protein for the
assembly of RISC, lead us to formulate a model according to which FMRP phosphorylation acts
as an on/off switch for the translation of PSD-95 through modulating RISC association, through
miR-125a.
Chapter 6.3 GQ formation in the 3’ UTR of BDNF DNA regulates APA. Transcript
shortening can lead to impaired translation and ultimately affect biological processes. Thus,
understanding how the body regulates the length of mRNA transcripts from the same gene is
significant to understanding this path of translational regulation. Previous studies have shown
that patients with decreased levels of the long 3’-UTR BDNF transcript have impaired mental
functioning, thus uncovering how the ratio of short: long BDNF 3’-UTR is regulated is important
to understanding this system. We have shown the formation of a GQ structure proximal to
poly(A) site 1 is leading to an increase in the short 3’-UTR BDNF transcript production. By
combining our in vitro biophysical characterization of the BDNF DNA GQ structure and the imotif with our collaborator’s in vivo data we have constructed a narrative that describes how the
GQ structure is directly leading to the production of the short 3’-UTR transcript. When the GQ is
disrupted by mutations an increase in the production of the long 3’UTR transcript is observed.
Additionally, we characterized the formation of the GQ in the BDNF mRNA 3’-UTR. It was
found that FMRP is specifically targeting this structure with a low nM affinity. This could mean
that the BDNF RNA GQ is acting as a regulator factor in conjunction with FMRP to help
facilitate the choice of the poly(A) site proximal to the GQ. BDNF acts as a model for a new
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potential mechanism of regulating poly(A) site choice and transcript shortening. The GQ
structure is the key to this mechanism, in BDNF and other similar sequences.
Chapter 6.4 GQ formation in pre-miR-149 inhibits miRNA maturation. Recent studies have
discovered that GQ formation in the miRNA pathway, in miRNA precursors, can influence the
maturation of those miRNAs. Analyzing the pre-miR-149 sequence uncovered the possibility for
a GQ structure to form. Additionally, a study observed that a naturally occurring single
nucleotide polymorphism, SNP, (A to G) in the sequence led to a significant decrease in levels of
mature miRNA-149. Analyzing the SNP sequence uncovered the possibility for a second GQ
structure to form. We then characterized these sequences and determined if the GQ was the
reason the SNP was producing less mature miRNA. Using an in vitro molecular beacon assay,
we were able to compare the relative amounts of mature miRNA produced by Dicer processing.
Our results indicate that the formation of a second GQ in the pre-miR-149 SNP leads to a
disruption in its processing by Dicer. This is significant and adds to the field another system
where GQ formation is modulating the production of miRNA.
Chapter 6.5 Significance. The work presented here is a compilation of projects that all fall
under the umbrella of the GQ structure roles in regulating translation. These projects are unique
systems that demonstrate non-canonical roles for GQ, expanding our understanding of the
biological function of these structures. In the NR2B gene, the GQ is acting to regulate translation
in a more direct way, by binding FMRP. In the PSD-95 project we show that the GQ formation
spanning the miR-125a binding site is acting to block canonical miRNA binding and regulation,
and that FMRP is required to help facilitate miR-125a binding (depending on the
phosphorylation state of FMRP). This project demonstrates another way GQ can be involved in
translation regulation. In the BDNF project, we show an indirect method for GQ to regulate

88

translation. By having GQ formation proximal to an APA site and disrupting the normal
distribution of transcript length (between long and short) the translation of the BDNF gene is
modified. This shows how GQ formation in the 3’ UTR proximal to a APA site can have an
effect on the transcripts eventual translation. This is another example of a noncanonical role for
GQ in translational regulation since the idea for GQ regulating APA has only really come to
fruition in the last 5 years.
Finally, in the pre-miR-149 project the GQ structure regulates translation indirectly by
modulating the expression levels of mature miRNA, which in turn affect the translation of
specific target mRNAs.
Translational regulation is one of the most important biological functions and
understanding the complex mechanisms the body uses to modulate protein levels is significant if
we, as the human race, are to develop techniques to combat the ever-growing field of human
disease.
Chapter 6.6 Future Works. There is additional work to be done in the field to elucidate the
deeper mechanisms by which GQ leads to translational regulation. We have shown that FMRP
targets GQ with its RGG box and can inhibit translation in this way. There are other proteins
with RGG box domains, such as FUS and EWS, that could use their RGG domains to target GQ
in a similar way.
The NR2B project has been published and fills its role, however it is only a small part of
a larger overall project in uncovering all the in vivo targets of FMRP and discovering the pattern
and mechanism by which FMRP targets and regulates these mRNA.
High resolution techniques can be incorporated in the miR-149 project to get a more
quantitative view of the mature miRNA levels to give a number to the disruption the GQ has on
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miRNA processing. Mass spectrometry can be used to quantitate the levels of mature miRNA
produced post-Dicer processing. This will give a deeper understanding of how the GQ inhibits
miRNA maturation. Additionally, another way to visualize the Dicer processing of pre-miR-149
would be to use radio labeled RNA to see all of the products produced and line them up with a
ladder to find the desired mature miR-149 band. Lastly, we want to investigate if FMRP is
influencing pre-miRNA processing. Incorporating FMRP and FMRP S500D into the Dicer assay
would give vital information about whether FMRP is involved in the miRNA pathway.
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Chapter 7: Materials and Methods
Chapter 7.1 RNA synthesis. Synthetic DNA templates (Trilink Biotechnologies, Inc.) were
synthesized by in vitro transcription using T7 RNA polymerase produced in-house [197].
Oligonucleotides were purified by 20% polyacrylamide, 8 M urea denaturing polyacrylamide gel
electrophoresis (PAGE), electrophoretically eluted, and dialyzed against 10 mM cacodylic acid,
pH 6.5. Samples containing fluorescent analogue, 2-aminopurine (Dharmacon, Inc.), were used
for steady-state fluorescence spectroscopy experiments. For specific nucleotide sequences please
refer to the table in each project chapter.

Chapter 7.2 Peptide Synthesis. The FMRP RGG peptide corresponding to its RGG region
(Figure 2) was chemically synthesized by the Peptide Synthesis Unit at the University of
Pittsburgh Center for Biotechnology and Engineering.

Chapter 7.3 FMRP protein expression and purification. FMRP Isoform 1 and its
phosphomimic FMRP S500D [70, 198] were expressed and purified as described [71]. Briefly,
the recombinant plasmids pET21a-FMRP encoding Isoform 1 fused with a C-terminal 6x
histidine tag and pET21a-FMRP S500D were transformed in Rosetta 2(DE3) pLysS E. coli cells
(Novagen). Single colonies were grown in 250 mL of LB + Ampicillin (Amp) +
Chloramphenicol (Chl) at 37°C for 12 hrs. Four sterile 2 L flask were prepared with 500 mL of
LB + Amp + Chl and 25 mL of the cell culture was added to each flask, followed by incubation
at 250 rpm at 37°C until an OD600 between 0.8–1.0 was reached.
The expression of FMRP Isoform 1 or FMRP S500D was induced by adding 1 mM
isopropyl β-D-1-thiogalactopyranoside (IPTG) to each flask, followed by incubation at 25°C for
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12 hrs. The cells were then harvested, lysed and purified using Ni-NTA resin (Qiagen). The
purified proteins were concentrated and dialyzed in a final buffer that contained 5% glycerol, 1
mM EDTA, and 300 mM LiCl. The concentration of the FMRP was determined by measuring
absorbance at 280 nm using an extinction coefficient of 46370 M-1 cm-1.

Chapter 7.4 Polyacrylamide gel electrophoresis. Prior to gel loading, RNA samples were
annealed by heating at 95°C in the presence of KCl and slowly cooled for 10 min at room
temperature on the bench. For binding experiments, the peptide was then added in varying ratios
and allowed to equilibrate at 25°C for 20 min. Samples were loaded onto 20% acrylamide:bisacrylamide gels and run at 88 V for approximately 4 hours, at 4°C. Gels were visualized by UVshadowing at 254 nm [199] or by staining with Syber Gold dye and imaged using an
AlphaImager (AlphaInnotech).
Alternative gel conditions were used to monitor longer sequences (pre-miRNA-149
WT/SNP) and binding with FMRP / FMRP S500D. Samples were run on a 15% polyacrylamide
gel at 88 V for approximately 2.5 hours at 4 °C and visualized by the same methods.

Chapter 7.5 1H NMR Spectroscopy. The 1D 1H NMR spectra were acquired using a 500 MHz
Bruker AVANCE spectrometer to analyze an RNA sample in 90% H2O and 10% D2O in 10 mM
cacodylic acid, pH 6.5 solution. GQ formation was observed by titrating KCl from a 2 M stock,
allowing for equilibration, and monitoring the imino proton resonance region at 10-12 ppm.
Water suppression was accomplished using the Watergate pulse sequence [200].
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Chapter 7.6 Circular Dichroism (CD) Spectroscopy. The CD spectra were collected using a
Jasco J-810 spectropolarimeter at 25°C, with scans from 180 nm to 400 nm, using a 200 μL
quartz cuvette (Starna Cells) with a 1 mm path-length. Each set of conditions was scanned three
times with a 1 sec response time and a 2 nm bandwidth. The spectra were corrected for solvent
contributions. For the K+-dependent GQ formation analysis, 10 μM RNA samples were annealed
in the absence of KCl and spectra recorded. KCl was then titrated and allowed to equilibrate
followed by spectra acquisition.

Chapter 7.7 UV spectroscopy thermal denaturation.

The UV/Vis spectroscopy thermal

denaturation experiments were performed on a Cary 3E UV/Vis Spectrophotometer (Varian,
Inc.) equipped with a peltier cell. 200 µL samples containing 10 mM KCl in 10 mM cacodylic
acid buffer pH 6.5 with varying RNA concentrations were annealed as described above and
thermally denatured by varying the temperature in the range 25 °C–95 °C, at a rate of 0.2
°C/minute and monitoring the absorbance changes at 295 nm, wavelength sensitive to GQ
denaturation [201]. In order to prevent sample evaporation, a layer of mineral oil was added to
the cuvettes. To study if an intermolecular or intramolecular GQ is formed with target sequence,
the UV/Vis spectroscopy thermal denaturation experiments were performed at variable RNA
concentrations ranging from 5–50 µM and a fixed KCl concentration in 10 mM cacodylic acid
buffer, pH 6.5.
In the case of G quadruplex structure formation between n number of RNA strands, the
melting temperature (Tm) depends on the total RNA concentration, equation (1).
∆ °

ln

∆ °
∆ °
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(1)

Whereas the melting temperature of an intramolecular GQ structure (n=1) is independent
of the RNA concentration, equation (2) [23], where R is the gas constant and ΔH°νH and ΔS°νH
are the Van’t Hoff thermodynamic parameters.
∆ °

(2)

∆ °

The thermodynamic parameters of the G quadruplex structures were obtained by fitting
their UV thermal denaturation curves to equation (3), which assumes a two-state model [23]
where AU and AF represent the absorbance of the unfolded and native G quadruplex RNA
structure, respectively, and R is the universal gas constant.
∆ °
∆ °

∆ °

∆ °

(3)

Chapter 7.8 Steady-state fluorescence spectroscopy. Steady-state fluorescence spectroscopy
experiments were performed on a Horiba Jobin Yvon Fluoromax-3 with accompanying software
fitted with a 150 W ozone-free xenon arclamp. Experiments were performed in a 150 µL sample
volume, 3-mm path-length quartz cuvette (Starna cells). The excitation wavelength for the 2-AP
containing samples was set to 310 nm with bandpass excitation and emission of the
monochromators set to 5 nm, and the emission recorded between 330-450 nm. For pyrrollo-C
experiments, steady-state fluorescence was monitored at 445 nm with excitation at 350 nm. All
binding experiments were performed at 23°C. Increasing concentrations of the respective peptide
or full-length protein were titrated against a fixed RNA concentration of 200 nM in 10 mM
cacodylic acid, pH 6.5, in the presence of KCl. Experiments were performed in the presence of
five-fold excess BSA or HCV specific peptide to reduce non-specific binding. Emission values
were corrected for free peptide or full-length protein and data normalized to free RNA
fluorescence intensity. Experiments were performed in triplicate, intensity was normalized for
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each experiment and plotted as a function of the peptide or protein concentration and fit to
Equation 4:
1

1

(4)

where IF and IB represent steady-state fluorescence intensities of free and bound RNA,
respectively. [RNA]t is the total fixed RNA concentration and [P]t is the total protein
concentration. The protein-RNA complex dissociation constant, Kd, was determined for each
experiment by fitting binding curves with Equation 4. Reported Kd represents an average of the
three Kd values and standard deviation from the average fit reported as error.
Chapter 7.9 Molecular Beacon Assay. Steady-state fluorescence spectroscopy was performed
on a FluoroMax4, equipped with a temperature control unit (HORIBA Scientific). Sample
volumes were 300 µL in 10 mM Tris buffer, Ph 7.4, 1 mM MgCl2. Final pre-miRNA-149
WT/SNP concentrations were 200 nM. 70 µM ATP was added to solution as well for Dicer
(Genlantis) to be active. Sample was incubated in a water bath at 37 °C for 2 hours, with premiRNA, ATP and 1 unit of Dicer (Genlantis). After incubation, 1 unit of Proteinase-K (New
England Biolabs Inc.) was added to solution and left to incubate at room temperature for 5
minutes to insure Dicer was successfully digested. The sample was then added to the cuvette and
placed in the fluorimeter at 23 °C. 25 nM molecular beacon was added to the sample and then
immediately capped. Scans were taken at 10-minute increments over a 16 hours period to
monitor the change in fluorescence from the beacon. Slits were set at 4 and 4 with excitation at
492 nm with a scanning range between 510-590 nm. The procedure was adapted from a study
that pioneered the use of this technique to study miRNA maturation [202].
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